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Abstract 
AMPA receptors (AMPARs) mediate majority of excitatory synaptic 
transmission, and are involved in fast neuronal glial signaling in the central 
nervous system (CNS). These receptors are tetrameric assemblies that 
function as homomeric or heteromeric combinations of four AMPAR 
subunits (GluA1-4). Many key AMPAR properties are determined by the 
GluA2 subunit, the absence of which renders the AMPAR calcium 
permeable. Calcium permeable AMPARs (CP-AMPARs) are relatively 
widespread in the CNS being present in certain neurons and many glia. 
The calcium permeability of neuronal AMPARs is known to be relatively 
plastic, changing during development and following high frequency 
synaptic activity. It is clear that calcium permeable AMPARs play an 
important role in normal functions of Bergmann glia and oligodendrocyte 
precursor cells, however factors that regulate the CP-AMPAR in glial cells 
are still poorly understood.  
Little is known about the transmembrane auxiliary AMPA subunit (TARPs) 
present in glial cells. In Chapter 3 of this thesis, I consider the role of 
transmembrane AMPAR regulatory proteins (TARPs) in controlling 
AMPAR channel properties and trafficking. In particular, these experiments 
identify γ-5 as a novel TARP that occurs mainly in glial cells, and is present 
at high levels in Bergmann glia. Functionally, this TARP appears selective 
for long form AMPAR subunits (predominantly calcium permeable). My 
experiments also demonstrate that γ-5 co-localizes with a late endosome 
protein. Uniquely, γ-5 appears selective for the trafficking of GluA2, and is 
dependent on the protein SAP97 for trafficking and/or localisation.  
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Oligodendrocyte precursor cells (OPCs), which are responsible for the 
formation of myelinating cells in the CNS, form a large proportion of the 
glial cells present in developing brain. OPCs are vulnerable to cell death in 
conditions such as periventricular white matter damage (hypoxic-ischemic 
white matter injury) in newborns. In Chapter 4, I have investigated factors 
that regulate calcium permeable AMPARs in OPCs, including mGluRs and 
purinergic receptors. Surprisingly I find that these receptors regulate 
calcium permeable AMPARs. This chapter identifies key mechanisms 
underlying this switch in AMPAR subtype, including the TARP γ-2 
(Stargazin) that is involved in mGluR-induced ‘plasticity’ of AMPARs in 
OPCs. The experiments described in the final chapter, investigates the 
transmembrane AMPAR regulatory protein cornichon-3 (CNIH3). In this 
thesis I identified that the AMPAR regulatory protein cornichon-3 (CNIH3) 
is expressed at the cell surface in OPCs and that when over-expressed 
can influence their AMPAR channel properties. 
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Introduction 
The majority of neuronal and glial communication in the central nervous 
system (CNS) is mediated by the excitatory neurotransmitter glutamate, 
which activates the ionotropic AMPA, kainate and NMDA receptors and the 
metabotropic glutamate receptors (mGluRs). The modification of glutamate 
receptors underlies several plasticity changes in the CNS, including long-
term potentiation (LTP), long-term depression (LTD) that have been linked 
to memory formation.  
LTP was first described in the hippocampus. The simple structure of the 
hippocampus enabled in vivo extracellular records of synaptic events for 
long periods (Bliss and Gardner-Medwin, 1973). Hippocampal LTP 
increases the strength of synaptic efficacy, which is associated with 
increased trafficking of AMPA receptors (AMPARs) to the synapse. This 
increased trafficking of AMPARs has been extensively characterised using 
electrophysiological, biochemical and molecular techniques (Luscher et al., 
2000). 
Persistent low frequency synaptic stimulation can result in LTD, which has 
been well-characterised at the parallel fibre to Purkinje cell synapses (PF-
PC) in the cerebellum and in the CA1 hippocampus. In CA1 hippocampal 
cells, LTD can be induced by long periods of low frequency synaptic 
stimulation (1-3 Hz, 5-15 min) of the CA3 Schaffer collateral axons. PF-PC 
LTD can also mimicked by applying the mGluR1 and mGluR5 agonist 
(R,S)-dihydroxyphenylglycine (DHPG) to external bathing solution for 
approximately 5–10 minutes (Bolshakov and Siegelbaum, 1994; Huber et 
al., 2000; Manahan-Vaughan, 2000). 
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Activation of mGluR1 on stellate cell interneurons of the cerebellum and 
neurons of the ventral tegmental area (VTA) results in a persistent 
increase in the insertion of synaptic calcium-impermeable AMPARs into 
the plasma membrane (Kelly et al., 2009; Mameli et al., 2007). 
Bergmann glia and oligodendrocyte precursor cells (OPCs) express 
calcium permeable AMPA receptors, which are important for regulation of 
synaptic communication with neurons. (Bellamy and Ogden, 2005) 
previously identified AMPA mediated plasticity in Bergmann glial cells 
(BGCs) after the stimulation of parallel fibers (PF) in the cerebellum. 
Recent studies have identified synaptic connections between neurons and 
oligodendrocyte precursor cells (OPCs), which have been shown to 
undergo changes in cell surface expression of CP-AMPARs after neuronal 
activation (Bergles et al., 2000; Ge et al., 2006). However the mechanisms 
that regulate this change in cell surface CP-AMPA expression in OPCs are 
not well understood. 
In this introduction I will be briefly summarizing some of the relevant basic 
molecular biology of AMPARs and their regulation by the transmembrane 
AMPA regulatory proteins (TARPs). I will also be describing briefly the key 
features of the G-protein coupled receptors mGluRs and P2Ys and their 
role in neuronal-glial communication. Finally I will describe background 
information about Bergmann glia and oligodendrocyte precursor cells.  
1.1. Glutamate receptors  
To date, three main classes of ionotropic glutamate receptors (iGluRs) 
have been identified: N-methyl-D-aspartate receptors (NMDARs), α-amino-
3-hydroxy-5-methyl-4-isoxazolpropionate receptors (AMPARs) and kainate 
receptors (KARs). Glutamate is also a ligand for the metabotropic
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glutamate receptors (mGluRs), which are important G-protein coupled 
receptors that are classified into 8 different subtypes (mGluR1-8). 
NMDARs were identified in the 1970s and eventually cloned in 1991, when 
studies revealed three families of receptors: GluN1, GluN2 and GluN3 
(formally NR1-NR3) (Moriyoshi et al., 1991). Between 1989 and 1992, 
AMPARs were first cloned and were found to have 4 distinct receptor 
subunits: GluA1, GluA2, GluA3 and GluA4 (formally GluR1-4) (Hollmann 
and Heinemann, 1994) (Collingridge et al., 2009).  KARs were identified in 
the 1990s and were found to have 5 subunits: GluK1, GluK2, GluK3, 
GluK4 and GluK5 (formally GluR5-7 and KA1-KA2) (Bettler et al., 1990). 
GluK1, GluK2, GluK3, and GluK4 all have high affinity for glutamate. 
However, while GluK1, GluK2 and GluK3 can form functional ion channels 
in the CNS, GluK4 and GluK5 cannot (Werner et al., 1991). 
1.1.1. AMPARs  
The structure of AMPARs has been elucidated through the use of x-ray 
crystallography and biochemical studies. The four identified AMPAR 
subunits (GluA1-4) share a 70% nucleotide sequence homology and are 
each approximately 100 kDa in molecular weight (Rogers et al., 1991). 
1.1.2. AMPAR structure 
AMPARs contain three transmembrane domains (M1, M3 and M4; M2 is a 
cytoplasmic re-entrant loop). Research suggests that the N-terminal 
domain of AMPARs is important for the regulation of AMPAR assembly 
(Kuusinen et al., 1999). In studies where the N-terminus of an AMPAR was 
exchanged with the N-terminus of kainate receptors, multiple properties of 
AMPARs were changed, including glutamate binding affinity and 
desensitisation kinetics (Stern-Bach et al., 1994; Stern-Bach et al., 1998). 
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High-resolution examination of X-ray crystal structures of AMPAR treated 
with the agonist kainate reveals that the extracellular domain of AMPARs 
contains the ligand-binding domain (LBD) (Figure 1.1B). Glutamate 
binding regions in the LBD were found to be in a conserved amino acid 
binding pocket (S1 and S2). The binding pocket is linked to the 
transmembrane domains (M1 and M3-4) in a clam shell-like binding core 
(Armstrong and Gouaux, 2000). Exchanging the ligand-binding domains of 
GluA3 with the ligand-binding domains of GluK2 resulted in profound 
changes to the affinity of glutamate for GluA3, highlighting the importance 
of the LBD in controlling the binding properties of agonists (Stern-Bach et 
al., 1994). 
1.1.3. Alternative splicing, editing and post-translational 
modification 
Splice variants of AMPARs for GluA2 and GluA4 occur at the C-terminus. 
Each variant results in the expression of either “long” or “short” form 
receptors. Short-form GluA2 and long-form GluA4 are the predominantly 
expressed forms in the CNS. Short-form GluA4 (GluA4c) have been 
observed in cerebellar granule cells (Gallo et al., 1992; Kohler et al., 1994). 
There are no identified splice variants for the short-form GluA3 or the long-
form GluA1 (Figure 1.1). All AMPAR genes encode two different splice 
variants in the extracellular loop between M3 and M4, known as ‘flip’ and 
‘flop’ (Monyer et al., 1991; Pei et al., 2009). The main functional difference 
between the flip and flop AMPARs are their desensitisation properties in 
response to prolonged glutamate activation; flop receptors desensitise 
more rapidly than flip receptors (Sommer et al., 1990). It is possible to 
delay the onset of desensitisation of flip AMPARs by applying the drugs 
cyclothiazide or aniracetam. Desensitisation of flop AMPAR isoforms can 
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be delayed with the addition of phenyoxyacetamide derivative PEPA 
(Kessler et al., 2000; Partin et al., 1994). 
The mRNA of GluA2 AMPAR subunit undergoes editing in the pore-lining 
region. Pore domain-editing results in the exchange of an uncharged 
glutamine with a positively charged arginine (Q/R) and renders GluA2R 
containing AMPA channels impermeable to Ca2+ (Burnashev et al., 1992b; 
Geiger et al., 1995). This editing is achieved through the enzymatic action 
of the RNA-dependent adenosine deaminase 2, resulting in 99% editing of 
GluA2 receptors in the adult brain.  
Increase in single-channel conductance is observed when an edited 
GluA2R is removed from AMPARs (Swanson et al., 1997). There are also 
significant changes to the whole-cell AMPARs rectification index (RI) 
measured from expression systems transfected with GluA2 containing 
AMPARs, producing a characteristic linear I/V relationship. The removal of 
GluA2R from AMPARs and an incorporation of CP-AMPARs produce an 
inwardly rectifying response (Figure 1.2).  
Defective editing of GluA2 receptors can result in the expression of 
GluA2Q and thereby lead to the excessive entry of Ca2+ into neurons, 
which has been implicated has been in a number of diseases including 
amyotrophic lateral sclerosis (ALS), stroke, Huntington's disease, 
Alzheimer's disease, malignant gliomas (Hideyama et al.; Rui et al., 2010; 
van Vuurden et al., 2009). 
AMPARs are further edited at the R/G site, which is controlled by RNA 
splicing of the flip/flop region, and results in alteration of the desensitisation 
properties of AMPARs. The unedited R form receptors desensitise more 
slowly than the edited G form (Seeburg et al., 1998). 
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Figure 1.1. Glutamate receptor classification and topology. 
(A) Glutamate receptor classification and their receptor subtypes. (B) AMPARs 
contain 3 transmembrane domains (M1, M3 and M4) with a ligand-binding domain 
(S1 and S2) and an extracellular N-terminal (NTD) and intracellular C-terminal 
domain (CTD). (C) AMPARs have flip and flop variants between the M3 and M4 
region that modify the properties of the receptors. Alternative splice variants of 
differing lengths in the C-terminus from GluA2 and GluA4. RNA editing may also 
occur within the M2 region at the Q/R site of GluA2, resulting in the formation of a 
calcium-impermeable GluA2R. Illustrations adapted from (Hansen et al., 2007) 
and (Dingledine et al., 1999). 
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Figure 1.2. Formation of tetrameric calcium-permeable and calcium-
impermeable AMPARs. 
(A) GluA2 edited at the Q to R site subunit represented in blue, and GluA1, GluA3 
and GluA4 represented in green. (B) AMPARs initially form dimers and then 
tetramers in the ER. The majority of AMPARs form heteromers, though 
homomeric receptors can also form stable AMPARs. (C) Heteromeric AMPARs 
that incorporate GluA2 are rendered impermeable to calcium, in contrast to 
tetrameric assemblies containing GluA1, GluA3 and GluA4, which are calcium-
permeable. (D) Whole-cell glutamate I/V plots are linear when cells express 
GluA2/GluA4. In contrast, GluA1/GluA4 containing AMPARs have an inwardly 
rectifying I/V relationship and a larger single channel conductance. Figure 
adapted from (Cull-Candy et al., 2006). 
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There is substantial glycosylation and phosphorylation of AMPARs in the 
trans-Golgi network (TGN). Mature synaptic AMPARs are heavily 
glycosylated, a property, which is thought to prevent degradation of 
receptors (Breese and Leonard, 1993; Hullebroeck and Hampson, 1992) 
Indeed, a lack of glycosylation of GluA3 results in degradation of the 
receptor and has been linked to Rasmussen's encephalitis (Gahring et al., 
2001).  
The phosphorylation of AMPARs is thought to be controlled by various 
kinases including Ca2+/calmodulin-dependent kinase II (CamKII), protein 
kinase A (PKA) and protein kinase C (PKC), all of which have been linked 
to AMPA plasticity during LTP (Barria et al., 1997; Mammen et al., 1997; 
Nayak et al., 1998). Indeed, Esteban and colleagues have demonstrated 
that PKA can control synaptic plasticity by controlling the phosphorylation 
of GluA4 at Ser842 and of GluA1 at Ser845 and furthermore the 
phosphorylation of both of these subunits during hippocampal LTP 
(Esteban et al., 2003). Further studies have linked the increased 
phosphorylation of GluA2 at Ser880 in Purkinje cells during cerebellar LTD 
(Chung et al., 2003). 
1.1.4. AMPAR binding proteins 
Synaptic AMPARs are regulated by interactions with PDZ binding proteins. 
These interactions have been identified using yeast-two hybrid screens 
carried out on the C-terminus of AMPARs. Experiments reveal a number of 
interacting proteins, including PICK-1, GRIP, NSF and SAP-97 (Dong et 
al., 1997; Srivastava et al., 1998; Wyszynski et al., 1998; Xia et al., 1999). 
These PDZ proteins are classified into groups depending on the identity of 
the last 4 amino acids in the C-terminal peptide. 
The class II PDZ binding proteins include PICK-1, GRIP and SAP-97, 
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which recognise the X-f-X-f sequence (X=unspecified amino acid and f = 
hydrophobic amino acid). Unedited and edited GluA2 short and GluA3 
interact with the PDZ domain containing the proteins ABP/GRIP and PICK-
1, while GluA1 interacts via its C-terminus with SAP-97 and with 
cytoskeleton protein 4.1 homologs (Leonard et al., 1998; Shen et al., 
2000). PICK-1, GRIP and NSF have been shown to control the trafficking 
of AMPAR from the plasma membrane after synaptic activation. 
Phosphorylation of GRIP has been shown to disrupt its binding to 
AMPARs, thus promoting internalisation of GluA2/GluA3 (Kim et al., 2001; 
Osten et al., 2000; Seidenman et al., 2003). 
Studies have also shown that PKC phosphorylates GluA2 at Ser880 after 
synaptic activation of hippocampal neurons, resulting in the binding of 
PICK-1 to GluA2 and initiating internalisation of the receptors (Hanley, 
2008). These findings were strengthened by overexpression of PICK-1 in 
the hippocampus, which resulted in decreased levels of synaptic GluA2 
(Dev et al., 1999; Terashima et al., 2004). Furthermore, the PDZ protein 
SAP97 has been shown to interact with GluA1-containing AMPARs in 
neurons and has been shown to increase both basal phosphorylation of 
GluA1 at Ser845 and its density at the synapse (Tavalin et al., 2002). 
1.1.5. AMPAR subunits and protein partners involved in LTP and LTD 
AMPARs present at the cell surface of neurons are highly dynamic and 
can be rapidly internalised and re-inserted into the synapse. The dynamic 
regulation of AMPARs has been shown to underlie some forms of plasticity 
during LTP and LTD. Several early studies have shown that during the 
induction of LTD, AMPARs are internalised (AMPAR containing GluA2 and 
GluA1), resulting in a loss of AMPAR density at the synapse whilst during 
LTP increased insertion of calcium-permeable GluA1-containing AMPAR in 
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hippocampal synapses occurs (Beattie et al., 2000; Man et al., 2000; Plant 
et al., 2006) Investigations of AMPAR during plasticity have revealed that 
AMPARs undergo rapid internalisation from the cell surface via association 
with clathrin and AP2, leading to the formation of clathrin-coated vesicles 
(CCVs) (Lee et al., 2002). Internalised AMPARs are then sorted to the 
early endosomes, from which they are sent either to the recycling 
endosomes for subsequent reinsertion into the plasma membrane, or to 
the late endosomes. AMPARs that are contained in the late endosomes 
are usually degraded by lysosomes (Ehlers, 2000) (Figure 1.3).  
Hippocampal LTD can be induced by brief application of NMDA, which has 
been shown to induce the rapid internalisation of synaptic AMPAR. This 
form of ‘chemically-induced’ LTD promotes increased co-localisation of 
AMPARs with the early endosome marker EEA1 (Ehlers, 2000).  The 
GluA2 binding proteins PICK-1, NSF and GRIP control the internalisation 
of AMPARs during LTD (Perez et al., 2001). In studies where hippocampal 
neurons were transfected with a GluA2 mutant that lacked the NSF binding 
domain for GluA2, the receptor localised to lysosomes, suggesting that 
NSF-GluA2 interaction is required for the recycling of GluA2 to the plasma 
membrane. Blocking the interaction between GluA2 and GRIP or its close 
relative ABP inhibits LTD, suggesting that removal of surface GluA2 
requires GRIP (Matsuda et al., 2000). PICK-1 has been shown to regulate 
the internalisation and the recycling of AMPARs to the plasma membrane. 
Using pH-sensitive tagged GluA2, Lin et al. (2007) demonstrated that 
receptors recycled more rapidly to the plasma membrane after chemical 
LTD in the absence of PICK-1 (Lin and Huganir, 2007).  
LTP has been associated with increased trafficking of GluA1 and unedited 
GluA2Q to the cell surface during hippocampal LTP. Previous studies have 
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shown that GluA1-containing AMPARs are trafficked from the recycling 
endosomes where they are inserted in the cell surface of hippocampal 
neurons following LTP (Park et al., 2004; Plant et al., 2006). 
Understanding the mechanisms that control AMPAR trafficking are 
important as in ischemia there is substantial oxygen glucose depravation 
leading to increased cell-surface expression CP-AMPARs in hippocampus 
resulting in the increased influx of Ca2+ and associated cell-death (Liu et 
al., 2006). 
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Figure 1.3. AMPAR trafficking and sorting. 
(1) In the endoplasmic reticulum, AMPARs are synthesised, assembled and 
targeted to the trans-Golgi network where they undergo extensive post-
translational modifications, including glycosylation and palmitoylation. (2) Mature 
AMPARs are trafficked from the tans-Golgi network in vesicles to the cytoplasm 
where they can either be stored (3) or trafficked to the cell surface membrane. At 
the cell surface membrane, AMPARs associate with proteins including PSD-95 
and SAP-97. (4) GluA2-containing AMPARs have been shown to undergo 
internalisation after treatment with NMDA. Internalisation is dependent on NSF, 
GRIP and PICK-1, as well as the binding of the protein AP2 to the C-terminus of 
GluA2, leading to the formation of clathrin-coated vesicles. (5) After internalisation, 
AMPARs are trafficked to the early endosomes where the receptors can either be 
directed to the recycling compartment (6) and sent back to the plasma membrane, 
or they are sent to the late endosomes and finally to lysosomes for degradation 
(8).  Image modified from (Hanley, 2010). 
1.1.6. Transmembrane AMPAR regulatory proteins (TARPs) 
Transmembrane AMPAR regulatory proteins (TARPs) are auxiliary 
proteins that control properties of AMPARs at excitatory synapses. TARPs 
were discovered in the mutant mouse ‘stargazer’. Initially, stargazer mice 
were thought to have a calcium channel mutation, but further examination 
revealed a lack of synaptic AMPARs in cerebellar granule cells. 
Subsequent experiments on these mice identified a mutation in the C-
terminus of the TARP Stargazin (Chen et al., 2000). In this section, I will 
describe the role of TARPs in controlling the properties of AMPARs.  
1.1.6.1. The TARP family of proteins 
Stargazin (γ-2) was the first TARP to be identified from a family of related 
proteins (γ-1, γ-3, γ-4, γ-5, γ-6, γ-7 and γ-8). Only five of these proteins are 
known to be functionally active (γ-2, γ-3, γ-4, γ-7 and γ-8). The roles of the 
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TARP-related proteins γ-1 and γ-6 remain unknown. In-situ hybridisation 
studies have identified that γ-2 is highly expressed in the cerebellum and is 
the only TARP expressed in cerebellar granule cells (Fukaya et al., 2005). 
1.1.6.2. TARPs control AMPA trafficking  
γ-2 increases trafficking of GluA1 to the cell surface by facilitating the exit 
of the receptor from the ER (Bedoukian et al., 2008). Studies have 
demonstrated that γ-2 also increases activation of the unfolded protein 
response, which increases ER protein folding capacity (Vandenberghe et 
al., 2005). AMPARs leaving the ER undergo phosphorylation and 
glycosylation in the trans-Golgi network. The glycosylation of immature 
AMPARs in the trans-Golgi network is enhanced by the expression of 
TARPs. Furthermore, cerebellar granule cells isolated from the stargazer 
mice contain a higher proportion of immature, glycosylated receptors 
failing to reach the synapse (Tomita et al., 2003). 
γ-2, γ-3, γ-4, and γ-8 have identical PDZ binding domains, which contain a 
TTPV amino acid motif on their C-termini. The C-terminal motif of TARPs 
interacts with a variety of proteins, including microtubule-associated 
protein 1 light chain 2 (MAP1-LC2), membrane-associated guanylate 
kinase (MAGI-2), neuronal isoform of protein interacting specifically with 
TC10 (nPIST), and synaptic scaffolding proteins postsynaptic density 
protein of 95 kDa (PSD-95) (Deng et al., 2006). nPIST is required for 
targeting AMPARs to the synapse via interaction with γ-2 in the TGN. 
When the AMPA-γ-2 complex is inserted into the membrane, the nPIST is 
released from γ-2 and recycled to the TGN (Cuadra et al., 2004) (Figure 
1.4). The PDZ TTPV domain of γ-2 has been shown to bind to PSD-95 and 
is required for synaptic targeting and clustering of AMPARs (Cuadra et al., 
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2004). Chen et al. (2000) also demonstrated the importance of the PDZ 
binding domain of γ-2; synaptic AMPA expression was rescued when 
stargazer granule cells were transfected with wild-type γ-2 protein. 
However, AMPAR expression was not rescued in stargazer granule cells 
transfected with a C-termini deletion of γ-2.  
 
 
 
 
 
 
 
Figure 1.4. TARPs increase cell surface trafficking of AMPARs. 
(1,2) AMPARs form tetramers in the ER and are exported to the Golgi. (3) In the 
Golgi, the protein nPIST associates with the C-terminus of γ-2 and, along with the 
proteins MAP1 and AP4, act to chaperone AMPAR to the plasma membrane. (4) 
AMPAR complexes diffuse to the postsynaptic density. (5,6) nPIST dissociates 
from the AMPA-TARP-PSD95 complex at the postsynaptic density and is recycled 
back to the Golgi. Figure adapted from Payne et al., 2008 (Payne, 2008). 
1.1.6.3. TARPs determine AMPAR channel properties  
TARPs regulate many fproperties of AMPAR channels, including receptor 
desensitisation, receptor deactivation and single-channel conductance. 
The effects of TARPs on AMPA properties have been investigated using 
rapid application (100 ms) of glutamate onto outside-out patches from HEK 
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cells that co-express AMPARs and γ-2, γ-3, γ-4, γ-7 and γ-8 (Figure 1.5a-c). 
These studies showed that TARPs significantly increase the AMPAR 
single-channel conductance, whilst having no detectable effect on the peak 
open probability (Po, peak). Furthermore, while all TARPs slow the 
desensitisation of AMPARs, γ-4 and γ-8 have the most dramatic effect on 
AMPAR desensitisation kinetics. Further investigation of the hippocampal 
AMPA receptor kinetics of γ-8 knockout mice revealed faster decay kinetics 
compared to wild-type controls (Rouach et al., 2005). 
TARPs have also been shown to modify the affinity of the AMPAR agonist 
kainate for this receptor. In studies of outside-out patches from GluA1-
containing AMPARs exposed to kainate prior to glutamate, a small partial 
response to kainate was observed. However, when GluA1 was co-
expressed with γ-2, kainate produced a large non-desensitising current. 
The increase in the peak kainate current can be measured against the 
peak glutamate current to produce a ratio: IKA/IGlu. The IKA/IGlu ratio is higher 
for AMPA co-expressed with γ-2 and γ-3 than the ratio for AMPA co-
expressed with γ-4 (Shi et al., 2009). TARPs also increase the affinity of 
the AMPAR for glutamate (Tomita et al., 2005a). The co-expression of 
AMPARs with γ-2, γ-3, γ-4 and γ-8 also reduces the half-maximal effective 
concentrations of glutamate (EC50) (Figure 1.5d) (Coombs et al., 
unpublished).  
One of the characteristic properties of calcium-permeable AMPARs is that 
they are blocked by intracellular polyamines at depolarising potentials 
(Bowie et al., 1998; Koh et al., 1995). Calcium permeable-AMPARs, which 
are associated with γ-2, have reduced sensitivity to a polyamine block at 
positive and negative potentials. Relief of the polyamine block in CP-
AMPARs when expressed with γ-2 results in decreased rectification when 
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compared with control cells, which lack γ-2 (Soto et al., 2007) (Figure 
1.5e).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. TARPs control properties of AMPARs. 
(a) The properties of heteromeric GluA1/GluA2 (GluR1/2) were examined with and 
without stargazin (stg), achieved using tsA201 cells transfected with AMPARs and 
removed outside-out patches exposed to 10 mM glutamate (100 ms) at -60 mV. 
Current-variance plots were obtained from non-stationary fluctuation analysis 
applied to patches from cells expressing GluA1/2 (control) and from cells 
	   26 
expressing GluA1/2+stg (stargazin). Stargazin (γ-2) significantly increased single-
channel conductance compared to control values.  (b) AMPAR traces obtained 
from control GluA1/2 and GluA1/2+stg expressing cells. Superimposed traces 
demonstrate the ability of stargazin to slow the desensitisation kinetics and 
increase the steady-state current. (c) Single-channel openings obtained from the 
tails of current traces from control GluA1 and GluA1+stg. Stargazin increased the 
single-channel conductance. (d) Glutamate dose-response from GluA1 control 
and GluA1+stg. Stargazin increased the affinity of glutamate for AMPARs. (e-g) 
CP-GluA1 receptors are blocked by intracellular polyamines at -60 mV, which 
results in changes to current-voltage (I/V) plots. Stargazin (γ-2) relieved the 
polyamine block of GluA1 receptors at positive and negative potentials, resulting in 
less inward rectification of the I/V response when compared to the response of 
GluA1 alone. Data obtained from (Coombs and Cull-Candy, 2009) and Soto et 
al., 2007. 
1.1.6.4. TARPs and disease 
The ability of TARPs to increase the conductance and slow the kinetics of 
AMPARs also influences synaptic communication (Chen et al., 2000). 
However, in pathological conditions, where increased influx of calcium 
through CP-AMPARs occurs, AMPARs can also influence neuronal cell 
damage. (Tomita et al., 2007) used γ-8 knockout mice to study the effect of 
TARPs on kainate toxicity and neuronal cell damage in the hippocampus.  
Kainate-induced damage of neurons in the hippocampus of γ-8 knockout 
mice was significantly reduced, possibly due to a reduced number of 
AMPARs on the cell surface and reduced AMPAR channel conductance, 
resulting in faster channel kinetics.  
Recent studies have further demonstrated that there is a correlation 
between mutations in the gene that encodes γ-2 with hearing loss, epilepsy 
and schizophrenia. These studies highlight the importance of TARPs in 
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controlling the properties of AMPARs and the potential for TARPs as 
therapeutic targets for neurological disorders (Kato et al., 2010).  
1.2. Metabotropic glutamate receptors 
mGluRs are G-protein coupled receptors (GPCRs) that are compromised 
of eight different subtypes. Group I mGluRs, (mGluR1 and mGluR5) can 
couple to Gq, which activates phospholipase C (PLC) and leads to an 
increase in intracellular calcium (Conn and Pin, 1997). Group II (mGluR2 
and mGluR3) and Group III (mGluR4, mGluR6, mGluR7 and mGluR8) 
receptors are linked to the inhibitory Gi/Go, which is negatively linked to 
adenylyl cyclase (AC) when expressed in expression systems (Hermans 
and Challiss, 2001). mGluRs are known to be involved in the induction of 
LTD in the cerebellar cortex. mGluR regulation of LTD in this brain region 
is dependent on the activation of mGluRs on Purkinje cell (PC) dendrites 
(Kano and Kato, 1987). Subsequent studies revealed that mGluR 
activation could induce LTD in several other brain regions, including the 
neocortex, hippocampus, midbrain and striatum (Feldman, 2009; Ito, 1996; 
Luscher and Huber, 2010). 
In the following section, I will briefly describe the role of group I mGluR in 
synaptic plasticity and communication in specific brain regions. 
1.2.1. mGluR-coupled intracellular secondary messenger systems 
and intracellular pathways 
mGluR1 and mGluR5 receptors are often linked to the Gq second 
messenger systems, which are sensitive to pertussis toxin (PTX) (Aramori 
and Nakanishi, 1992; Houamed et al., 1991; Prezeau et al., 1992). The 
activation of either Group I subtype triggers the cleavage of 
phosphatidylinositol 4,5 bisphosphate into diacylglycerol (DAG) and 
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inositol 1,4,5-trisphosphate (IP3) by PLC, which leads to increased release 
of intracellular calcium by activation of the IP3 and ryanodine receptors 
present on the surface of the ER (Verkhratsky, 2002) (Figure 1.6 pathway 
3). 
Activation of mGluR1 has been linked to increased protein synthesis by 
activating PI3K and Akt, both of which are part of the mTOR pathway in 
mammalian cells (Banko et al., 2006; Hou and Klann, 2004). mGluR1 and 
mGluR5 are directly coupled to the Homer proteins 1a, 1b, 1c, 2, and 3 
(Brakeman et al., 1997). The mGluR-Homer-PI3K pathway leads to 
activation of 5’TOP-containing mRNA, thereby enhancing protein 
translation (Ronesi and Huber, 2008) (Figure 1.6 pathway 1). Homer 
proteins are highly enriched at glutamatergic synapses and interact with 
PI3K enhancer, which has been linked to neuroprotection. When activated, 
this process can prevent apoptosis (Rong et al., 2003). The activation of 
group I mGluRs has been linked to the activation of the MAPK/MEK-JNK 
pathway by the protein Rap1 (Cavalli et al., 2001). Furthermore, the JNK 
protein kinases are activated by the ERK pathway, which is activated after 
the binding of glutamate to mGluR1 {Li, 2007 #5873; Huang et al., 2004). 
Activation of mGluRs is known to modify the properties of receptors, 
including GABAA, certain K+ channels, AMPARs and voltage-gated 
calcium channels (VGCC). In cerebellar granule cells, tandem pore 
potassium channels (TASKs) are inhibited by activation of mGluR1 and 
mGluR5 (Chemin et al., 2003). In cerebellar PCs and hippocampus the 
stimulation of mGluRs modifies properties of GABAergic currents, and in 
retinal amacrine cells activation of group I mGluRs have been shown to 
influence the activation of the calcium-calmodulin pathway, which in turn 
inhibits GABAA receptors (Hoffpauir and Gleason, 2002; Llano and Marty, 
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1995; Poncer et al., 1995). The activation of mGluR1 in cerebellar PCs 
results in PKC-dependent phosphorylation of the C-terminus of GluA2 
Ser880 and the release of GRIP, allowing endocytosis of AMPARs from 
the cell surface (Chung et al., 2003). By contrast, the activation of mGluR1 
in CA1 pyramidal neurons triggers the internalisation of AMPARs in a 
PKC-independent manner, which in this instance is regulated by the 
dephosphorylation of tyrosine residues on the C-terminus of GluA2 
(Gladding et al., 2009). 
Recent studies have linked mGluR1-mediated internalisation of AMPARs 
to the enzymatic activity of TACE, which cleaves Aβ amyloid and is 
involved in Alzheimer’s disease (AD). There is also evidence that 
hippocampal neurons transfected with Aβ1-42 (a mutant AD peptide) have 
significantly reduced lateral mobility in of mGluR5 in the membrane. This 
deficit in mGluR mobility could be linked to the cognitive deficits that occur 
in AD (Renner et al., 2010). 
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Figure 1.6. Model of mGluR1 and mGluR5 activated intracellular pathways. 
(1) mGluR1 and mGluR5 activation initiates an increase in protein synthesis via 
the PI3K-Akt-mTOR pathway. This activation can be inhibited by cyclohexamide 
(C-hex). (2) mGluR5 stimulation leads to activation of the epidermal growth factor 
kinase (RTK), triggering activation of the downstream kinase JNK and initiating 
transcription. (3) Binding of glutamate to mGluR1 and mGluR5 leads to the 
cleaving of phosphatidylinositol 4,5- bisphosphate into diacylglycerol (DAG) 
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inositol 1,4,5-trisphosphate (IP3) by PLC. This cleaving leads to the release of 
intracellular calcium through the IP3 and ryanodine receptors present on the cell 
surface of the ER. (4) mGluR1 activation leads to the phosphorylation of STEP 
and dephosphorylates the tyrosine residue to the C-terminus of GluA2, triggering 
internalisation (5) mGluR5 stimulation leads to increased release of intracellular 
Ca2+ causing association of the calcium-sensing protein (NSC-1), PICK-1 and 
PKC. This association results in phosphorylation of GluA2, which in turn triggers 
endocytosis and removal from the synapse during LTD. Illustration adapted from 
Jo et al., 2008, Ferraguti et al., 2008 (Jo et al., 2008) (Ferraguti et al., 2008). 
 
1.3. Purinergic receptors 
Like glutamate, adenosine triphosphate (ATP) is also a major 
neurotransmitter in the CNS. ATP activates purinergic receptors, which 
have been shown to regulate hippocampal synaptic plasticity (Wang et al., 
2004). Purinergic receptors are divided into two classes, together 
consisting of eight family members of P2Y receptors (P2Y1, P2Y2, P2Y3, 
P2Y4, P2Y6, P2Y11 and P2Y12): ion channels (P2X) and GPCR-linked (P2Y 
receptors) (Abbracchio et al., 2009; Fredholm et al., 1994). P2Y receptors, 
are distributed within the CNS, but are also found in non neuronal cells 
where they regulate platelet aggregation and blood clotting (Moers et al., 
2003). 
P2Y metabotropic purinoreceptors have a structure similar to mGluRs, as 
both of are 7-transmembrane domain G-protein coupled receptors. P2Y 
purinoreceptors, P2Y1, P2Y2, P2Y4, P2Y6 P2Y11 and P2Y14 receptors are 
coupled to the excitatory Gq and have the ability to form heteromeric 
assemblies, which are present in many cell types (Fields and Burnstock, 
2006). ATP binds to the P2Y1 receptors, triggering formation of DAG and 
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IP3 and eliciting the release of Ca2+ from the ER. In contrast P2Y12 and 
P2Y13 are negatively linked to adenylyl cyclase.  
The P2Y1 and P2Y2 receptors are present in a variety of brain regions, 
including the hippocampus, hypothalamus and prefrontal cortex. P2Y4 and 
P2Y6 are present in the cerebellum and hippocampus. ATP application has 
been shown to activate inward current responses from dorsal horn neurons 
in the spinal cord (Jahr and Jessell, 1983). Subsequent studies on brain 
slices demonstrated the presence of miniature synaptic currents, which 
were blocked with the competitive purinergic receptor antagonist suramin 
(Edwards et al., 1992). This study suggests that ATP was able to act as a 
neurotransmitter in the CNS. mGluR and P2Y receptors are highly 
localised in several glial cell types and have important roles in neuronal-
glial communication, which will be discussed in the next section.  
1.4. Glial cells 
Glial cells are categorised into astrocytes, microglia and oligodendrocytes. 
Astrocytes include cerebellar Bergmann glia, which ensheathe PCs and 
express CP-AMPARs (GluA1, GluA4) that are activated by glutamate 
released from climbing fibres (CF) and parallel fibres (PF) onto purkinje 
cells (PC) synapses. The release of glutamate activates CP-AMPARs on 
Bergmann glia cells (BGCs) are important for mediating for neuronal-glial 
communication.  
Oligodendrocyte precursor cells (OPCs) are widely distributed in the 
developing CNS and form myelinating oligodendrocytes. Several studies 
have revealed that OPCs express a mixture of calcium permeable and 
calcium impermeable AMPARs (GluA2, GluA3, GluA4), studies have also 
shown that OPCs can form synapses with hippocampal neurons and can 
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undergo AMPAR plasticity after neuronal activation (Bergles et al., 2000; 
Ge et al., 2006). 
In this section I will be briefly describing the role of Bergmann glia CP-
AMPARs for neuronal-glial communication. I will also be summarising the 
role of oligodendrocyte precursor cells in the CNS. 
1.4.1. Bergmann glia  
BGCs are the major radial glial cell of the cerebellum and have an 
important role in the axon guidance of Purkinje cells (PCs) and granule 
cells during the development of this region (Ango et al., 2008). BGCs also 
ensheathe PF and CF synapses. BGC currents produced by the release of 
glutamate induced by the stimulation of CFs and PFs have been shown to 
be generated by the activation of calcium permeable AMPARs and 
electrogenic glutamate transporters (Bergles et al., 1997; Clark and 
Barbour, 1997) (Figure 1.7A). BGCs express a high density of the 
glutamate transporters GLAST and GTL-1, which have important roles in 
regulating the levels of extracellular glutamate released after the 
stimulation of the granule cell layer and parallel fibres (Bergles et al., 1997; 
Takayasu et al., 2006). CP-AMPARs (GluA1 and GluA4) are activated by 
the release of glutamate from PF and CF synapses. (Iino et al., 2001) 
highlighted the importance of CP-AMPARs for the ensheathment of PCs. 
Overexpressing GluA1 in BGCs resulted in maintenance of the 
characteristic rod-like structure, with lateral appendages radiating from the 
shaft (Figure 1.7C(a)). However, BGCs virally transfected with GluA2 had 
significant retraction of lateral appendages and less ensheathment of PCs, 
in addition to reduced clearance of glutamate (Figure 1.7C(b)). The 
normal activation of BGC AMPARs is known to arise from spillover of 
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transmitter from CF-PC synapses (Bergles et al., 1997) and from quantal 
release originating from CFs and PFs (Matsui et al., 2005) (Figure 1.7B).  
The release of glutamate from PCs has also been shown to induce short-
term plasticity of extrasynaptic AMPARs in BGCs (Bellamy and Ogden, 
2005). In this study, the extrasynaptic currents (ESCs) were recorded from 
BGCs in response to two stimulation pulses of the PFs, which were 
separated by 10, 100 and 500 ms at a baseline frequency of 0.033 Hz 
(Figure 1.7D). The stimulation of the PFs produced a 4.2-fold facilitation of 
the BGCs extrasynaptic responses, known as paired pulse facilitation 
(PPF) that was blocked by the AMPA antagonist NBQX. The tetanic 
stimulation of PFs, for 10 pulses at either 10 Hz or 100 Hz, also initially 
facilitated the BGC ESCs, though this was followed by rapid depression in 
the amplitude of the BGC responses. Following this study, (Bellamy and 
Ogden, 2006) demonstrated depression of the BGC ESC AMPAR 
component and uptake currents after repetitive stimulation of the PFs.  
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Figure 1.7. CF-PF synapses release transmitter onto ensheathing Bergmann 
glia cell processes.  
(A-B) Cerebellar climbing fibres make synaptic connections with Purkinje cells 
(PCs), which are encapsulated by Bergmann glial cells. Bergmann glia express 
CP-AMPARs that are activated through ectopic release of glutamate from Purkinje 
cells (C) Expression of calcium-impermeable AMPARs (GluA1) in BGCs alters the 
ensheathment of CF-PC synapses. Images (left) from control BGCs (blue) 
transfected with calcium-permeable AMPARs have normal connectivity with 
synapses. BGCs transfected with calcium-impermeable GluA2 (blue) have 
retracted processes. (D) Traces of paired-pulse facilitation (PPF) of BCG 
extrasynaptic currents (ESC). The ESCs were recorded in response to two 
stimulation pulses of parallel fibres, which were separated by varying durations 
(10, 100 and 500 ms). Panel A adapted from (Beierlein and Regehr, 2005), 
Figure B taken from (Matsui et al., 2005), image C taken from (Iino et al., 
2001) and figure D taken from (Bellamy and Ogden 2005).  
 
1.4.2. Oligodendrocyte precursor cells  
 
Oligodendrocyte precursor cells (OPCs) form a major component of the 
glial cells in the mammalian developing central nervous system (CNS), 
however thet only form 5% of the glial cell population in the adult CNS. 
These cells were initially isolated from the optic nerve in pioneering work 
by Raff and colleagues (Ffrench-Constant and Raff, 1986; Raff et al., 
1983). The optic nerve was an ideal preparation for the isolation of OPCs 
as it is a relatively accessible tissue containing OPCs along with no 
neuronal cells bodies (Barres et al., 1988). Raff et al., 1983 demonstrated 
that it was possible to distinguish OPCs from neurons and other glial cells 
present in the nerve express as OPCs express distinctive O-Antigens on 
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their cell surface. O-Antigens, which are sulfatides, are differentiation 
markers expressed on the surface of oligodendrocytes. O4 is an O-Antigen 
that is used as a marker for cell bodies and processes of OPCs (Bansal et 
al., 1989). Expression of O4 occurs from day 3 onwards in OPC cell 
cultures. While the majority of OPCs express O4, a subset of OPCs does 
not. This subset of OPCs expresses NG2+, chondroitin sulphate (Trotter et 
al., 2010). 
It is possible to maintain OPCs in a precursor phase using two mitogens: 
basic fibroblast growth factor (bFGF) and platelet derived growth factor 
(PDGF-α) (Shi et al., 1998). These mitogens both stimulate the 
proliferation of OPCs in culture. The removal of these mitogens and the 
addition of thyroid hormones to immature OPCs trigger their differentiation 
into oligodendrocytes (Barres et al., 1994). Oligodendrocytes begin to 
produce myelin basic proteins (MBP) and the O-Antigen O1, which are 
absent in precursor cells (Figure 1.8). 
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Figure 1.8. Differentiation of O2A progenitors into oligodendrocytes.  
Purified perinatal progenitor cells are initially bipolar (identified with the marker 
A2B5). Under conditions where growth factors are present, cells will begin to 
differentiate and become highly branched. At this stage OPCs can be identified 
with the marker O4. The removal of mitogens leads to differentiation into 
Specific markers 
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myelinating oligodendrocytes identifiable with the marker MBP and O1. Figure 
adapted from (Levine et al., 2001). 
The ability to selectively isolate OPC in culture allowed investigations into 
the electrophysiological properties of OPCs, resulting in the identification of 
glutamate evoked responses from OPCs (Usowicz et al., 1989). Further 
studies examining the expression of AMPAR protein from cultured cortical 
OPCs, revealed the AMPA subunits present of GluA2, GluA3 and GluA4 
mRNA and protein in OPCs (Itoh et al., 2002). This study also revealed 
that the expression level of the calcium permeable AMPARs subunits 
GluA3 and GluA4 are dramatically reduced in differentiated myelinating 
oligodendrocytes suggesting that these cells mainly express calcium 
impermeable GluA2. The activation of AMPARs in OPCs is required for 
migration, through the their interaction with integrin proteins complex 
(Gudz et al., 2006). In contrast there is evidence that suggests that 
glutamate inhibits the migration and maturation of OPCs (Yuan et al., 
1998). In addition, the presence of CP-AMPARs in OPCs has been linked 
to an increased vulnerability of OPCs to cell death (Deng et al., 2003). 
(Bergles et al., 2000) demonstrated that CP-AMPARs expressed on OPCs 
activated by glutamatergic inputs from CA1 neurons in the hippocampus, 
which were blocked in the presence of the AMPAR antagonist NBQX 
(Bergles et al., 2000). Ge et al., (2006), then demonstrated that the release 
of glutamate from CA1 hippocampal neurons produced AMPAR plasticity 
in NG2+ OPCs, resulting in a decrease in presence of cell surface CP-
AMPARs. This study was the first to demonstrate that AMPARs on OPCs 
can undergo changes in response to receiving glutamate from neurons 
(Figure 1.9). An increased insertion of CP-AMPARs during periods of 
neuronal activation is potential therapeutically important as expression of 
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CP-AMPARs on OPCs can increase the risk of cell death during periods of 
oxygen and glucose deprivation (Deng et al., 2006). 
A further examination of the receptor expression profile in an OPCs cell 
line (CG4 cells) has shown so far that these cells express mGluRs 
(mGluR3 and mGluR5) (Lyut et al., 2003). Functionally activation of 
mGluR5 by the agonist DHPG in an OPC immortalised cell line (CG4-
OPCs) has been shown to increase the levels of intracellular Ca2+ (Luyt et 
al., 2003). A2B5+ OPCs isolated from the cortex express mGluR1 
expression that is a dramatically reduced in expression after two days in 
culture (Deng et al., 2004). However the expression levels of mGluR5 
remain high for prolonged periods in cultured OPC.  
OPCs have also been shown to express purinergic receptors (P2Y1, P2Y2, 
P2Y4, P2Y6, P2Y11 and P2Y13 that are activated by the neurotransmitter 
ATP (Fields et al., 2006). ATP is know to be released from nerve terminals 
and from glia and appears to have a role in neuronal-glia communication 
(Cotrina et al., 2000). ATP mediates synaptic transmission and is co-
released with other neurotransmitters, including GABA and acetylcholine 
(Silinsky and Redman, 1996). Astrocytes have also been shown to release 
ATP, which can regulate neuronal activity (Guthrie et al., 1999).  
Several studies have identified the expression of purinergic receptors on 
astrocytes, oligodendrocytes and microglia (Table 1.11) (Fields and 
Burnstock, 2006). Using calcium imaging on astrocytes, ATP has been 
shown is important for glia-glia communication and is responsible for the 
propagation of Ca2+ waves. Utilizing genetic and pharmacological 
techniques it has been possible to demonstrate that multiple mechanisms 
lead to the release of ATP from glial cells (Wang et al., 2000). ATP also 
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has been shown to produce an increase in intracellular Ca2+ in NG2+ 
OPCs, which is inhibited by the antagonists suramin and PPADS (Hamilton 
et al., 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.11. Expression profile of P2Y and P2X receptors in astrocytes, OPCs 
and oligodendrocytes. Adapted from Fields and Burnstock et al., 2006. (+) 
denotes functional evidence for the expression of ionotropic and 
metabotropic purinergic receptors.  
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Figure 1.9. Synaptic communication between neurons and OPCs in the 
hippocampus. 
(A) Electron micrographs of biocytin-filled OPCs (black cells) which are receiving 
synaptic inputs from neuronal cell bouton (b) (white arrow) and a neuronal spine 
(s) (Bergles et al., 2000). (B-C) Comparison of the effects of glutamate release 
from neurons on the functional properties of NG2+-OPC AMPAR properties. 
Excitatory postsynaptic AMPAR recordings from NG2+ cells were made before 
and after theta burst activation of neuronal cells (10 Hz) inducing the release of 
glutamate. NG2+ recordings were made at +40 and -60 in the presence of 
intracellular spermine. Theta burst activation of neurons results in increased 
amplitude of postsynaptic NG2+ AMPAR responses at +60mV. This increased 
amplitude of AMPAR response is indicative of an increased presence of CP-
AMPARs in the cell surface of NG2+-OPCs after the release of glutamate from 
neurons (Ge et al., 2006). A taken from (Bergles et al., 2000), B adapted from 
(Ge et al., 2006).  
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2. Materials and methods  
 
2.2.1. Cerebellum glia-neuron co-culture 
All procedures were carried out in accordance with the UK Home office 
license (Scientific procedures) Act 1986. P7 Rats were deeply 
anesthetized with isoflurane and decapitated. The cerebellum was 
dissected from the brain and immersed in 1x Hanks balanced salt solution 
(HBSS) (Sigma) and maintained at 40C on ice. Cerebellar tissue was then 
minced and subsequently dissociated in 5mls of 1x HBSS containing 20 
units/ml of papain containing 0.5mM EDTA and 1.65 mM L-cysteine 
(Worthington) for 30 minutes at 370C. Tissues were then triturated 10 times 
with a pasture pipette and centrifuged for 10 minutes at 1000 r.p.m. The 
pellet was resuspended in 2.4mls of papain inhibitor solution (ovomucoid 
protease inhibitor bovine, serum albumin and DNAase) (Worthington) and 
centrifuged for 10 minutes at 1000 r.p.m and plated onto 12mm coverslips 
coated with 100µg/ml poly-l-lysine at a density of 100 cells per coverslip. 
Culture media consisted of 1x Basal Medium Eagle (BME) (Sigma) 
containing 2mM glutamine, 10% FCS and penicillin/streptomycin (500 
units/per 500mls) (Gibco). Cultures were maintained at 370C in a 
humidified incubator gassed with 5% CO2. The cultures were fed three 
times a week with 1xBME + FCS for 7 days (Randall and Tsien, 1995). 
2.2.2. Spinal cord glia-neuron co-culture  
Spinal cords were dissected from embryonic day 17 (E17) Sprague-
Dawley rats (5-8 embryos). The spinal cords were removed and placed in 
1XHBSS, minced and then incubated in an enzyme solution containing 
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Earle's salts, 20 units/ml papain (Worthington), 0.5mM EDTA and 1.65 mM 
L-cysteine (Sigma) for 20 min at 37°C as described above. The tissue was 
triturated by passages through a Pasteur pipette in complete astrocyte-
conditioned media consisting of Earle's minimum essential medium (MEM) 
(Sigma) containing 10% fetal bovine serum, penicillin/streptomycin (500 
units/each), and 20 mM glucose (Gibco). The supernatant was discarded, 
and the cells resuspended and plated onto polyornithine/laminin-coated 
(100µg/ml) glass coverslips (12 mm circular) at a density of 100 cells per 
coverslip. The cultures were fed three times a week with complete 
astrocyte-conditioned medium for 7 days (Robert et al., 2000). 
2.2.3. Co-immunoprecipitation from heterologous cells 
tsA201 cells were grown in 10 cm2 dishes until a confluent monolayer was 
formed. Cell were then transfected with equal amounts of AMPAR and 
YFP-γ-5 cDNA using lipofectamine 2000 (invitrogen). After 24h of 
transfection, cells were washed with 1 x phospho buffered saline (Sigma) 
and lysed in 1ml of TNE buffer (50 mM Tris-HCl, pH, 8.0, 150 mM NaCl, 1 
mM EDTA, 0.5% Triton X-100 plus 10µl protease inhibitor cocktail (Roche) 
and solubilized by rotating 1 h at 40C. Solubilized membranes were then 
centrifuged for 10 min, at 14,000g (40C). The pellet was discarded and the 
lysate membranes were placed in a new centrifuge tube. 50µl of the lysate 
was placed in an aliquot at denatured at 950C in 50µl of Laemmli sample 
buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% 
bromphenol blue and 0.125 M Tris HCl, pH approx. 6.8.) to serve as the 
input protein sample. The remaining solubilized membranes were then 
incubated with 1 mg of rabbit anti-GFP (Invitrogen) or rabbit IgG control at 
40C. After 24 h lysates were incubated with 20 µl of protein G bound to 
sepharose beads (Sigma) (1 h, 4 °C), and centrifuged for 10mins at 1300 
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r.p.m. The pellets were washed 2X in TNE buffer containing 300mM NaCl 
and once in TNE buffer. The pellets containing the bound proteins were 
eluted with SDS sample buffer by boiling (5 min, 95 °C). 
Immunoprecipitated samples and cell lysates were separated by SDS-
PAGE followed by western blotting with mouse anti-GluA2 or rabbit anti-
GluA1 (Chemicon; Millipore UK) and anti-GFP (Invitrogen) (Soto et al., 
2009).  
2.2.4. Co-immunoprecipitation from rat brain 
Cerebellar tissue were removed from P20 three rats were placed in buffer 
A (50 mM Tris-HCl, 0.5% Triton X-100, 150 mM NaCl, 1 mM 
phenylmethylsulfonyl fluoride, 1 mM EDTA, and protease inhibitor cocktail; 
Roche) and solubilized for 1 h at 40C. Tissue was centrifuged (50,000g, 45 
min, 4 °C) and the lysate incubated overnight with 1 mg of antibody to γ-5 
(anti–γ-5; Sigma-Aldrich). After 24 h, the lysate was incubated with 20 µl of 
protein G–Sepharose (Sigma; 1 h, 4 °C). The protein G pellet was washed 
three times in buffer A. Adherent protein was separated on an SDS gel. 
The proteins were transferred onto nitrocellulose and blotted with anti-
SAP97 (1:100) or anti-GluA4 (1:100; both Santa Cruz Biotechnology). As 
internal controls, we also incubated lysates with either anti-TARP (γ-2, γ-8) 
antibody or anti-GluA1 (both Millipore) (Soto et al., 2009). 
2.2.5. Cell surface biotinylation of AMPARs 
tsA201 cells were grown in 10 cm2 dishes and transfected with cDNA for 
AMPAR subunits and either GFP (as control) or γ-5. After 24 h, cells were 
chilled on ice and washed them twice with ice-cold PBS containing 1 mM 
MgCl2, 2.5 mM CaCl2. The cells were then treated (20 min on ice) with 1 ml 
of 1mg/ml of sulfo-NHS-biotin (Pierce) in 1XPBS. Un-reacted biotinylation 
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reagent was quenched by washing the cells three times for 5 min with 50 
mM glycine in 1XPBS containing 1mM Mg2+ and 2.5mM Ca2+, followed by 
two washes in ice-cold 1XPBS containing Mg2+ and Ca2+. Cells were 
harvested in RIPA buffer (Perbio) and solubilized by rotating (1 h, 4 °C). 
Homogenates were centrifuged (14,000g, 10 min, 4 °C) and the input 
aliquot removed. The remaining supernatant was incubated (3 h, 4 °C) with 
20 µl of 50% UltraLink Immobilized NeutrAvidin Protein (Pierce). After 
incubation, the NeutrAvidin protein was washed twice with high-NaCl RIPA 
buffer (500 mM NaCl) and once with low-NaCl RIPA (150 mM NaCl), and 
bound proteins were eluted with SDS sample buffer by boiling (5 min, 95 
°C). Western blotting was carried out using an XCell SureLoc Novex Mini-
Cell system (Invitrogen). The biotinylated proteins were probed using 
antibodies to GluA1, GluA2 and GluA4 (Chemicon). Immunoblots were 
visualized by ECL development (GE Healthcare Life Sciences) and 
quantified on a calibrated densitometer (Bio-Rad GS-800) (Soto et al., 
2009). 
2.2.6. Confocal fluorescence imaging 
Fluorescence images were acquired with LEICA confocal microscope and 
a ×63 oil immersion lens using LSF software. Immunostaining for glia and 
neurons were carried out under permeabilized conditions using 0.5% 
Triton, in PBS. Image analysis was carried out with Image J software 
(public domain software developed at the US National Institutes of Health).  
2.2.7. CG4 OPC cells 
CG4 cells are an OPC cell line obtained from Elek Molnar (University of 
Bristol). The cells were used between passages 13 and 22, and were 
grown in chemically defined modified Sato medium containing 30% (v/v) 
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B104 conditioned medium. The modified Sato medium consisted of: 
Dulbecco's modified Eagle's medium (DMEM), 0.1% (w/v) bovine serum 
albumin fraction V, 60 µg/L progesterone, 16.1 mg/L putrescine, 5 µg/L 
sodium selenite, 400 µg/L tri-iodothyronine, 400 µg/L (T3), 50 mg/L holo-
transferrin, 5 mg/L insulin and 2 mM L-glutamine. Cells were cultured in a 
humidified atmosphere at 37°C with 5% (v/v) CO2. Glass coverslips were 
coated with poly-L-lysine (100 µg/ml). 72 hrs prior to electrophysiological 
studies cells were treated every 24 hours with DMEM + Sato with 10ng/ml 
PDGF-AA and bFGF (Louis et al., 1992; Luyt et al., 2003). 
2.2.8. BI04 cells 
 B104 cells were grown in DMEM containing 10% (v/v) heat-inactivated 
fetal calf serum (FCS; Gibco UK) and 2 mM L-glutamine until 70% 
confluent. Cells were maintained with DMEM + modified Sato medium for 
a period of 4 days. B104 medium used to maintain the CG-4 cells in the 
proliferative.  
2.2.9. OPC cell purification 
All procedures were in accordance with the UK Animals (Scientific 
Procedures) Act 1986.  Optic nerve OPC purified by immunopanning. 
Optic nerves were obtained from postnatal day 7 (P7) rats. Tissues were 
diced and digested in trypsin 0.05%/EDTA and then gently dissociated for 
30 minutes at 370C. Dissociated P7 optic nerves were sequentially 
immunopanned on Thy-1 (AbD Serotec), anti-galactocerebrosidase 
(GalC) (Millipore), and then O4 antibody (R and D systems) plates where 
finally used to select GalC–O4+ OPCs. Purified OPCs to be cultured were 
transferred to poly-L-lysine (pLL) (Sigma) coated 24-well tissue culture 
plates containing proliferation medium. All cells were cultured at 37°C, 5% 
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CO2 in DMEM (Invitrogen) containing human progesterone (60 ng/ml), 
sodium selenite (40 ng/ml), N-acetyl-L-cysteine (5 µg/ml), bovine insulin 
(5 µg/ml) (Sigma UK), glutamine (2 mM), transferrin (100 µg/ml), bovine 
serum albumin (100 µg/ml), putrescine (16 µg/ml), sodium pyruvate (1 
mM) and penicillin–streptomycin (100 U each) (Sigma UK), Proliferation 
medium also contained OPC mitogens PDGF-AA (10 ng/ml) and bFGF 
(10ng/ml) (both from R and D systems) (Barres et al., 1988). 
2.2.10. OPC differentiation 
Immature OPC cells were differentiated into pre-myelinating OPCs with 
the withdrawal of mitogens; basic fibroblast growth factor and platelet 
derived growth factor from the conditioned media. The DMEM+Sato 
medium was supplemented with thyroxine (T3) (Sigma T6397) for 48 
hours. Cells were immunolabeled with anti-O4 to and anti-myelin basic 
protein to confirm adult pre-myelinating OPCs (Dugas et al., 2010). 
2.2.11. Transfections 
Optic nerve OPCs were grown on poly-L-lysine (PLL) glass coverslips and 
maintained with basic fibroblast growth factor and platelet derived growth 
factor for a maximum of 7 days. Cells were transfected with 2µg of DNA 
using the calcium phosphate transfection (Invitrogen). Cells were used for 
experiments 24 hours after transfections. TARP cDNAs (rat; γ-2) was a gift 
from Roger Nicoll (UCSF). Mutagenesis was performed using PCR, with 
mismatch primers obtained from Sigma Genosys (Poole, UK): 
2.2.12. Immunofluorescence 
Cerebellum neuronal-glial cultures grown on PLL coverslips for 10 days 
were washes 3X with PBS and were fixed with 4% PFA in 1X PBS for 10 
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minutes at 25oC. Cells were then incubated with in blocking solution (1x 
PBS containing 2% BSA (Sigma UK), (Sigma) 10% horse serum 
(Invitrogen UK) and 0.5% Triton) for 20 minutes. Coverslips were 
incubated with rabbit anti-γ-5 (Sigma) 1/100, mouse anti-MAP2 (Abcam) 
1/50, mouse anti-EEA1 (Abcam) 1/100, mouse anti PDI rabbit anti γ-2/γ-8 
(Millipore) 1/20 for 1 hour at 250C. Coverslips were finally labeled with 
1/1000 rabbit anti donkey Alexa-568 and 1/1000 mouse anti-rabbit 488 
(Invitrogen UK) for 1 hour at 25oC. All coverslips was mounted on anti-
fade medium (Invitrogen UK).  
In chapter 2 OPC cultures were grown on PLL coverslips and fixed with 
4% PFA in 1X PBS for 10 minutes. Fixed cells were washed with 3x 
1XPBS. Cells were then incubated with blocking solution in 1x PBS 
(250mg BSA (Sigma UK), (Sigma) 10% horse serum (Invitrogen UK)), and 
then permeabilized with 0.5% Triton (Sigma) for 20 minutes. Coverslips 
were incubated for 1 hour with mouse anti-O4 (1/100) (R and D systems) 
and with rabbit anti- γ−2/γ−8 (Millipore) (1/50) at 250C. Coverslips were 
washed 3x with blocking solution and finally labeled with rabbit anti 
donkey Alexa-568 (1/1000) and mouse anti-rabbit 488 (1/1000) 
(Invitrogen UK) in blocking solution for 1 hour at 250C. All coverslips were 
washed with 1XPBS mounted on anti-fade medium (Invitrogen UK).  
2.2.13. RNA extraction 
RNA was isolated from the rat optic nerve using TRIZOL (Invitrogen), and 
RT-PCR was carried out by using 1µg of RNA in a Retroscript kit 
(Invitrogen), and 5µl of the reverse transcriptase (RT). The products were 
amplified using the SuperTaq (Ambion) in 30 cycles of 940C(1min)/600C 
with 720C(7min) after the last cycle. The PCR primers were used γ-
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1:Forward:GCGGGGGAAAAGAATTGReverse:CAGAGCCCTGCAAAGG
;γ2:F:ACTACGAGGCTGACACCGR:ACTTAGACCTGCAGACACGAAGlγ3
:F:GCTGCTTAGAAGGAGCTTTCCR:GTTGCTTAGCCCTGCAGAG;γ4:F:
CATCGAAGGCATCTACAAGGR:GATATTACTGAGGCCTGCAGC;γ5:F:G
CTTCCTCGCAGGTGAGR:AAGAGAGAGGCCGGATAGGγ6:F:TGCCAG
GAGAAGCAAACTGR:AGCAGCAGGCCTGAGAG;γ7:F:TTCTTTGCAGGT
CGGGAGR:CAAGGACAGGCCTGATAAAATG;γ8F:CCTGGAAGGGTTGA
AAAGAGR:TGATGTTGCTCAGGCCTG. The DNA products were resolved 
by using a 1% agarose gel.  
2.3. Electrophysiological recordings  
2.3.1. Patch electrodes  
Patch electrodes were made from thick walled borosilicate capillary tubing 
(GC-150F; Harvard Apparatus Ltd, Edenbridge, UK) using a two-step 
puller (Narishige, Japan). The electrical capacitance of the electrodes were 
reduced by coating with Sylgard (Dow Corning 184), which was solidified 
using a heated coil.  
2.3.2. Fast agonist application to excised patches 
Outside-out patches were obtained using electrodes fabricated from 
borosilicate glass (1.5 mm o.d., 0.86 mm i.d.; Harvard Apparatus, 
Edenbridge, UK) with a resistance of 8–12 MΩ. Rapid solution switching 
at the patch was achieved by piezoelectric translation of an application 
tool. The tool was made from theta glass (2 mm o.d.; Hilgenberg GmbH, 
Malsfeld, Germany) pulled to a tip opening of ~200 μm, and was mounted 
on a piezoelectric translator (Burleigh LSS-3000/PZ-150M; EXFO Life 
Sciences & Industrial Division, Mississauga, Ontario or P-265.00, Physik 
Instrumente, Waldbronn, Germany). Control and agonist solutions flowed 
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continuously through the two barrels and solution exchange occurred 
when movement of the translator was triggered by a voltage step. To 
visualize the solution interface and allow measurement of solution 
exchange (see below) 2.5 mg/ml sucrose was added to the agonist 
solution and the control solution was diluted by 5%. Recorded currents 
were low-pass filtered at 10 kHz and digitized at 20 or 50 kHz. At the end 
of each experiment, the adequacy of the solution exchange was assessed 
by destroying the patch and measuring liquid-junction current at the open 
pipette; the 10–90% risetime was always <200 μs. 
2.3.3. Non-stationary fluctuation analysis (NSFA) 
To analyze the channel properties from macroscopic responses, 
glutamate (10 mM) was applied to outside-out patches (100 ms duration, 
1 Hz) and the ensemble variance of all successive pairs of current 
responses calculated using IGOR Pro 5.05 (Wavemetrics, Lake Oswego, 
OR) and NeuroMatic (http://www.neuromatic.thinkrandom.com). The 
single-channel current (i), total number of channels (N) and maximum 
open probability Po, max) were then measured by plotting this ensemble 
variance (σ2) against mean current (Ī) and fitting with a parabolic function:  
 
 Where σ2B is the background variance. Along with expected peak-to-peak 
variation in the currents due to stochastic channel gating, some patches 
showed gradual changes in peak amplitude. The mean response was 
calculated from epochs containing 20–200 stable responses that were 
identified by using a Spearman rank-order correlation test (NeuroMatic). 
The weighted-mean single-channel conductance was calculated from the 
single-channel current and the holding potential (corrected for the 
Supplementary Text and Figures Soto et al. Nature Neuroscience 2009
◦C) from outside-out membrane patches or from isolated whole cells using an Axopatch 200A
amplifier and acquired using a Digidata 1200 interface board and pClamp software (Molecular
Devices Corporation, Sunnyvale, CA).
1.4 Fast agonist application to excised patches
Outside-out patches were obtained using electrodes fabricated from borosilicate glass (1.5 mm
o.d., 0.86 mm i.d.; Harvard Apparatus, Edenbridge, UK) with a resistance of 8–12 MΩ. Rapid
solution switching at the patch was achieved by piezoelectric translation of an application tool as
described previously [1]. The tool was made from theta glass (2 mm o.d.; Hilgenberg GmbH,
Malsfeld, Germany) pulled to a tip opening of 200 µm, and was mounted on a piezoelectric
translator (Burleigh LSS-3000/PZ-150M; EXFO Life Sciences & Industrial Division, Mississauga,
Ontario or P-265.00, Physik Instrumente, Waldbronn, Germany). Control a agonist solutions
flowed continuously through the two barrels and solution exchange occurred when movement of
the translator was triggered by a voltage step (pClamp). To enable visualization of the solution
interface and allow measurement of solution exchange 2.5 mg/ml sucrose was added to the
agonist solution and the control solution was diluted by 5%. Recorded currents were low-pass
filtered at 10 kHz and digitized at 20 or 50 kHz. At the end of each experiment, the adequacy
of the solution exchange w s assessed by destroying the patch and measuring liquid-junction
current at the open pipette; the 10–90% risetime was always <200 µs [1].
1.5 Non-stationary fluctuation analysis (NSFA)
To deduce channel properties from macroscopic responses, glutamate (10 mM) was applied to
outside-out patches (100 ms duration, 1 Hz) and the ensemble variance of all successive pairs
of current responses calculated using IGOR Pro 5.05 (Wavemetrics, Lake Oswego, OR) and
NeuroMatic (http://www.neuromatic.thinkrandom.com). The single-channel current (i), total
number of channels (N) and maximum open probability (Po, peak) were then determined by
plotting this ensemble variance (σ2) against mean current (I¯) and fitting with a parabolic function:
σ2 = iI − I¯2/N + σ2B (1)
where σ2B is the background variance. Along with expected peak-to-peak variation in the
currents due to stochastic channel gating, some patches showed gradual changes in peak amplitude.
In all cases, the mean response was calculated from epochs containing 20–200 stable responses,
which were identifi by sing a Spearman rank-order correlation test (NeuroMatic). The
weighted-mean single-channel conductance was calculated from the single-channel current and
the holding potential (corrected for the calculated liquid-junction potential). Po, peak was estimated
by dividing the average peak current by iN.
1.6 Comparison of AMPAR deactivati n and BGC quantal event decay
AMPAR deactivation, measured at room temperature (22–25 ◦C) in response to 1 ms applications
of 1 mM glutamate in the presence of 50 µM cyclothiazide was fit with a double exponential
2
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calculated liquid-junction potential; see above). Po,max was estimated by 
dividing the average peak current by iN.  
2.3.4. Rectification index I/V calculation and analysis 
Whole cell recordings from isolated oligodendrocyte precursor cells 
(OPCs) were achieved using thick-walled electrodes with a resistance 4-7 
MΩ. The pipette was filled with internal recording solution containing 100 
µM spermine giving a final resistance of 5-10MΩ. Input and series 
resistance was monitored throughout the duration of recording. A voltage 
ramp protocol was used to change the holding potential (–100 mV to +60 
mV at a rate of 162.5 mV/s; with the voltage held at –100 mV for 200 ms). 
Records were filtered at 2 kHz and sampled at 5 kHz. AMPARs were 
activated by a bath application of 100µM glutamate. During the recordings 
control OPCs had an average whole cell capacitance of 10 ± 1.2pF, 
(whole cell compensation (30-60%) were utilized). For chapter 2 OPCs 
were pre treated with 100 µM DHPG for 30 minutes and then placed in 
the recording chamber containing external solution containing DHPG. 
Initially 5 control sweeps I/V recordings were obtained to determine 
background current without glutamate which could be an indication of 
voltage gated channels (Figure 2.3.4.1). The glutamate is then bath 
applied to the cells until the baseline current is stable. The rectification 
index (RI) is the determined by initially subtracting the background current 
from traces with agonist.  The glutamate ramp IV plots were then plotted 
against a model cell I/V recording (+60/-100) and normalized. The 
rectification index was calculated by dividing the normalized value current 
at +60 and at -60mV. Waveforms were imported into IGOR version 6.1 
(Wavemetrics, Lake Oswego, OR) and recordings were analysed using 
Neuromatic (http://www.neuromatic.thinkrandom.com).  
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Figure 2.3.4.1. Measuring AMPA receptor rectification in CG4-OPCs in 
control and post-mGluR activation. 
(A) Representative AMPAR responses of CG4 cells to bath applied 100µM in the 
presence of AP5, gabazine, TTX and strychnine. The current voltage relationship IV is 
obtained from the whole cell glutamate response at membrane potentials between -60 
and +100. The rectification index for this cell has been calculated from current at +60mV 
and the extrapolated current at -100mV. (B) Whole cell AMPAR response to glutamate 
from CG4 cells treated with 100µM DHPG for 30 minutes.  
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2.4. Solutions and drugs 
 
 
 
 
 
 
 
 
 
 
External solution composed in mM.  The solution pH was set to 7.3 
using NaOH. 
 
 
 
 
 
 
 
 
Internal solution composes in mM. The solution pH was set to 7.3 with 
CsOH (285± 5 mOsmol/l). Internal solution always contained 100mM 
spermine dihydrochloride.   
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2.5. Chemical names 
 
 
Cyclohexamide 
 
Inhibits protein 
synthesis  
 
4-[2-(3,5-Dimethyl-2-
oxo-cyclohexyl)-2-
hydroxyethyl]-2, 6-
piperidinedione (Tocris) 
 
Spermine 
 
Blocks CP-
AMPARs 
N,N'-Bis(3-
aminopropyl)-1,4-
butanediamine 
tetrahydrochloride 
(Sigma) 
 
KN-62 
 
 
Inhibits CamKII and 
P2X7 receptors 
activity  
-[(2S)-2-[(5-
isoquinolinylsulfonyl)me
thylamino]-3-oxo- 3-(4-
phenyl-1-
piperazinyl)propyl] 
phenyl 
isoquinolinesulfonic acid 
ester (Tocris) 
 
 
TTX 
 
 
 
Na+ channel 
blocker 
Octahydro-12-
(hydroxymethyl)-2-
imino-5,9:7,10a-
dimethan o-10aH-
[1,3]dioxocino[6,5-
d]pyrimidine-
4,7,10,11,12-pentol 
(Tocris) 
 
DHPG 
 
Agonist at the 
mGluR1 and 
mGluR5 receptors  
 
(S)-3,5-
Dihydroxyphenylglycine 
(Tocris) 
 
 
Wortmannin 
 
 
PI3K inhibitor  
1S,6br,9aS,11R,11bR) 
11-(Acetyloxy)-
1,6b,7,8,9a,10,11,11b-
octahydro-1-(metho 
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xymethyl)-9a,11b-
dimethyl-3H-furo[4,3,2-
de]indeno[4,5,- h]-2-h]-
2-benzopyran-3,6,9-
trione (Sigma) 
 
 
ACDPP 
 
Antagonist of the 
mGluR5  receptor 
3-Amino-6-chloro-5-
dimethylamino-N-2-
pyridinylpyrazinec 
arboxamide 
hydrochloride (Tocris) 
 
MCPG 
 
Antagonist for the 
Group I/II mGluR  
 
S)-a-Methyl-4-
carboxyphenylglycine 
(Tocris) 
 
 
SP600215 
 
Inhibits JNK activity 
 
Anthra[1-9-cd]pyrazol-
6(2H)-one (Tocris) 
 
Strychnine 
 
Antagonist for the 
glycine receptor  
Strychnidin-10-one 
hydrochloride (Tocris) 
 
BAPTA-AM 
 
Calcium chelator 
1,2-Bis(2-
aminophenoxy)ethane-
N,N,N',N'-tetraacetic 
acid 
tetrakis(acetoxymethyl 
ester) (Tocris) 
 
SR95531 
 
Antagonist for 
GABAA receptors 
6-Imino-3-(4-
methoxyphenyl)-1(6H)-
pyridazinebutanoic acid 
hydrobromide (Toris) 
 
GYKI 52466 
 
Antagonist for 
AMPA receptors 
4-(8-Methyl-9H-1,3-
dioxolo[4,5-
h][2,3]benzodiazepin-5-
y l)-benzenamine 
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dihydrochloride (Tocris) 
 
 
PhTX-433 
 
 
Blocker of CP-
AMPARs  
tris(trifluoroacetate) salt, 
(S)-N-[4-[[3-[(3-
Aminopropyl)amino]pro
pyl]amino]butyl]-4-
hydroxy-α-[(1-
oxobutyl)amino]benzen
epropanamide 
tris(trifluoroacetate) salt 
(Sigma) 
 
 
Kainate 
 
Agonist for AMPA, 
kainate and NMDA 
receptors  
(2S,3S,4S)-Carboxy-4-
(1-methylethenyl)-3-
pyrrolidineacetic acid 
(Sigma) 
ATP 
Magnesium 
Agonist for 
Purinergic 
receptors  
Adenosine 5'-
triphosphate (Sigma) 
 
RHC 80267 
 
Inhibits 
Diacylglycerol 
(DAG) degradation 
Pyridoxalphosphate-6-
azophenyl-2',4'-
disulfonic acid 
tetrasodium salt (Tocris) 
 
 
AP5 
Antagonist for the 
NMDA receptors  
D-(-)-2-Amino-5-
phosphonopentanoic 
acid (Tocris) 
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2.6. Additional drugs and concentrations used 
 
 
 
 
 
 
 
 
 
 
2.7. Frequently used abbreviations  
 
AMPA 
α-amino-3-hydroxyl-5-
methyl-4-isoxazole-
propionate 
 
mGluR 
Metabotropic glutamate 
receptors  
 
CP-AMPARs 
Calcium permeable 
AMPA receptors 
RI Rectification index  
P2Y Purinergic receptor 2Y 
OPC Oligodendrocyte 
Compounds Concentration 
DHPG 100µM 
BAPTA-AM 20µM 
Cyclohexamide 20µM 
ATP 1mM 
PPADS 10µM 
ACDPP 10µM 
MCPG 1mM 
AP5 20µM 
Strychnine 1µM 
Gabazine/ SR95531 20µM 
TTX 1µM 
Cyclothiazide 50µM 
Wortmannin 100nM 
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precursor cell 
TARPs Transmembrane AMPA 
receptor regulatory 
proteins  
NSFA Non stationary fluctuation 
analysis 
O4 O-Antigens expressed on 
the surface of OPCs 
 
2.8. Statistics  
 
All data are representative of trials repeated a minimum of 5 times across 
separate cell culture isolations unless otherwise indicated. Data are 
presented as mean±S.E.M. Multiple group differences were examined 
using a Kruskal-Wallis rank sum test followed by pair wise Wilcoxon rank 
sum tests with Holm’s sequential Bonferroni correction (R 2.9.2, The R 
Foundation for Statistical Computing). For measuring the difference 
between two populations unpaired T-test with post hoc Tukey tests, or 
Mann-Whitney tests (in cases where tests of normality failed) were used to 
identify significant differences between treatment conditions.  
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Chapter 3. The novel TARP γ-5 regulates AMPA 
receptor trafficking and channel properties 
3.1. Summary  
TARPs γ-2, γ-3, γ-4, γ-7 and γ-8 have been shown to control the properties 
and trafficking of AMPARs in many if not all central neurons (Chen et al., 
2000; Rouach et al., 2005). However, no TARPs have been reported that 
specifically regulate CP-AMPARs.  
Contrary to expectation, we found that the stargazin protein family member 
γ-5, widely used as a negative control, act as a functional TARP and 
specifically regulates CP-AMPARs in Bergmann glia. The experiments 
described in this chapter demonstrate that, unlike other TARPs, γ-5 is 
highly expressed in a number of glial cell types, including those in the 
olfactory bulb and the spinal cord.  
Furthermore, we have shown that γ-5 reduces cell surface expression of 
homomeric GluA2 receptors by increasing degradation of the receptor. 
These results suggest an important role for γ-5 in regulating the functional 
contribution of CP-AMPARs. 
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3.2. Introduction  
TARPs are vital for AMPAR-mediated signalling (Milstein and Nicoll, 2008; 
Priel et al., 2005). The loss of γ-2 expression in mice (Stargazer) has been 
shown to produce a loss of AMPAR trafficking to the cell surface of granule 
cells in the cerebellum and ataxia in mice (Chen et al., 2000). The protein 
γ-5 is related to the Stargazin family of proteins. However, it does not have 
the ability to ‘rescue’ AMPAR responses in granule cells from γ-2-lacking 
stargazer mice. Therefore, γ-5 was not thought to be a TARP, and has 
been widely used as a negative control in experiments on TARPs (Tomita 
et al. 2003). 
This chapter initially addressed the question of whether γ-5 is capable of 
modifying properties of CP-AMPARs. We found that γ-5 selectively 
regulated the functional properties of those AMPARs that contain long-form 
subunits, including AMPARs containing the GluA2Long (GluA2L) and 
homomeric GluA1 and GluA4. 
Although we find that γ-5 can control AMPAR properties when co-
expressed in transformed HEK293T cells (tSA201), its physiological role is 
more difficult to address. In-situ hybridisation studies have previously 
identified mRNA for γ-5 and the TARP γ-4 in cerebellar Bergmann glial 
cells (BGCs). Furthermore, γ-5 mRNA has been detected in several other 
brain regions, including the hippocampus, thalamus, striatum and several 
layers of the olfactory bulb (Fukaya et al., 2005). BGCs express only CP-
AMPARs containing GluA1 and GluA4, which are activated during neuron-
glia signalling. Given that γ-5 is intensely expressed in cerebellar BGCs, 
and that neuron–glia communication in these cells is dependent on CP-
AMPARs, we have considered whether γ-5 is involved in signalling 
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between neurons and BGCs (Iino et al., 2003; Matsui et al., 2006; 
Burnashev et al., 1992). 
3.3. Results 
3.3.1. γ-5 regulates AMPAR channel properties  
To examine whether γ-5 acts as a TARP, AMPARs were co-expressed 
with γ-5 in recombinant tsA201 cells. Patches were excised from the 
membrane of transfected cells and currents were obtained by the rapid 
application of 10 mM glutamate onto outside-out patches. This study 
initially compared responses from cells transfected with GluA4 alone with 
those obtained from cells expressing GluA4 + γ-5 or GluA4 co-transfected 
with one of the recognised TARP family members (γ-2, γ-3, γ-4, γ-7 and γ-
8) (Figure 3.1A-B).  
All previously established TARPs significantly increased AMPAR single-
channel conductance (estimated from Non-stationary fluctuation analysis). 
TARP γ-2 increased the channel conductance of homomeric GluA4 
receptors (20.1 ± 1.3 to 31.4 ± 2.5 pS; P = 0.0016, n = 8 and 9 cells, 
respectively). Interestingly, γ-5 also produced a marked increase in single-
channel conductance of homomeric GluA4 AMPARs (from 20.1 ± 1.3 to 
36.0 ± 2.6 pS; P = 0.0001, n=8 and 7 cells). The magnitude of the 
conductance increase seen with γ-5 was comparable to the conductance 
increase obtained with each of the previously established TARP family 
members. This unexpected finding, that γ-5 increased the single channel 
properties of AMPARs suggested that it is binding to, and modifying 
AMPARs properties (Figure 3.1C).  
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We next examined the effects of γ-5 on two AMPAR current parameters 
that contribute to the overall efficacy of the receptor population: the 
probability that agonist-bound channels will open (peak open probability, 
Po,peak) and the speed of desensitisation (τdes). Whereas Po,peak for 
homomeric GluA4 AMPARs was not altered by co-expression with the 
established TARPs, it was markedly decreased by co-expression with γ-5 
(from 0.57 ± 0.03 to 0.33 ± 0.03; P < 0.0001, n = 8 and 7) (Figure 3.1D). 
However, γ-5 did not alter the desensitisation kinetics of GluA4 (3.47 ± 
0.27 ms for GluA4 vs. GluA4+γ-5 3.01 ± 0.16 ms with γ-5, P = 0.1731, n = 
8 and 7; compared to 5.7 ± 0.7 ms for γ-2, P = 0.0114, n = 9) (Figure 
3.1E). This observation highlights the unique properties of γ-5 in 
decreasing the Po,peak of AMPARs without modifying the channel kinetics 
(3.47 ± 0.27 ms for GluA4 versus 3.27 ± 0.36 ms with γ-7; P = 0.6525, n = 
8 and 5) (Figure 3.1E). The TARP γ-7 and γ-5 have similar protein 
sequence in the C-terminus and γ-7 like γ-5 also has little effect on the 
properties of AMPAR kinetics, suggesting that the C-terminus of TARPs 
are responsible for the effects on AMPARs kinetics.  
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Figure 3.1. γ-5 modifies the channel properties of homomeric GluA4 
AMPARs. 
tsA201 cells were transfected with GluA4 and each individual member of the 
stargazin family of proteins (γ2, γ3, γ4, γ5, γ7 and γ8). Twenty-four hours post-
transfection, the GluA4 channel properties were measured in outside-out 
membrane patches exposed to fast application of 10 mM glutamate applied for 
100 ms (see Methods). (A-B) Current variance traces were obtained from tsA201 
cells expressing either GluA4 alone or together with γ−5. NSFA was used to obtain 
conductance values for GluA4 AMPARs. (C) Bar graphs compare the effect of the 
different TARPs (γ-5, black; other TARPs, gray; no TARP, white) on the estimated 
mean single-channel conductance. γ-5 significantly increased the conductance of 
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GluA4 from 20.1 ± 1.3 to 36.0 ± 2.6 pS; P = 0.0001, n=8 and 7 patches. (D) The 
probability of agonist-bound channel opening (peak open probability, Po,peak) 
GluA4 was markedly decreased by γ-5 (from 0.57 ± 0.03 to 0.33 ± 0.03; P = 
0.0001, n = 8 and 7). (E) The time constant of the decay of receptor 
desensitisation (τ des) for GluA4 was not increased compared with GluA4 + γ-2 - 
γ−8 (3.47 ± 0.27 ms for GluA4 vs. 3.01 ± 0.16 ms with γ-5, P = 0.1731, n = 8  and 
7 cells; compared to 5.7 ± 0.7 ms for γ-2, P = 0.0114, n = 9 cells). Error bars are 
s.e.m. The work for this figure was carried out in collaboration with David 
Soto. We each carried out equal amounts of work to produce this figure.  
3.3.2. γ-5 regulates the long-form CP-AMPARs 
γ-5 was not thought to be a TARP because it failed to rescue cell surface 
AMPARs or synaptic responses in stargazer granule cells (Tomita et al., 
2003). Previous studies have shown that cerebellar granule cells express 
predominately the short-form calcium impermeable GluA2/GluA4c 
subunits. The results shown in Figure 3.1 demonstrate that γ-5 behaves 
like a TARP when co-expressed with a long-form CP-AMPA.  Therefore, it 
seems possible that γ-5 does not modulate the properties of AMPARs in 
cerebellar granule cells either because they do not express calcium 
permeable subunits, or because they lack long-form AMPAR subunits. To 
address this issue we examined the properties of continuum of AMPARs 
assemblies, from homomeric GluA4 to heteromeric GluA2/4, in the 
absence and the presence of γ-5 expressed in tsA201 cells (Figure 3.2A). 
The same series of experiments were then repeated using AMPARs 
assemblies composed of entirely of long-form AMPAR subunits. This was 
achieved using long-form GluA2L rather that short-form GluA2s (Figure 
3.2B).  
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To determine the properties of AMPARs co-expressed with γ-5, outside-out 
patches were excised and exposed to 10 mM glutamate and obtained a 
wide range of rectification values (RI+60/-60 0.07–1.35). It is possible to 
distinguish GluA2R containing AMPARs as the rectification index (RI = 
+60mV/-60mV) produced were between 0.4-1.35 as polyamines do not block 
GluA2R containing AMPARs. However when GluA4 alone is transfected in 
tSA201 cells the RI ranges between 0.3-0.07 as polyamines block the pore 
of this CP-AMPARs at positive membrane potentials. We next plotted 
single-channel conductance as a function of RI, after grouping data 
according to whether patches showed a low (<0.4), intermediate (0.4–0.8) 
or high (>0.8) RI. For patches in which most receptors were expected to be 
homomeric GluA4 (transfected with a low proportion of GluA2R cDNA, and 
yielding a low RI), γ-5 produced a significant increase in single-channel 
conductance (from 13.4 ± 2.3 pS to 27.1±2.6 pS; n = 8 and 7 respectively; 
P = 0.0017) (Figure 3.2A). Similarly, conductance increased in patches 
with intermediate RI values (from 8.0 ± 0.8 pS to 15.4 ± 1.5 pS; n = 6 and 
9; P = 0.0023). However, γ-5 had no significant effect on conductance for 
patches with a high RI (high proportion of heteromeric GluAR2/GluA4 
assemblies) (8.7 ±1.1 pS with γ-5 versus 6.0 ± 1.1 pS without γ-5, n = 10 
and 6; P = 0.1303). This suggested that γ-5 selectively modifies the 
properties of, or selectively traffic, certain CP-AMPAR assemblies. This 
finding was unexpected, as no other TARP seems to be able to modify or 
deliver specific AMPAR subtypes. 
To investigate whether γ-5 is selective for long form AMPAR subunits, cells 
were transfected with GluA2L, which in common with GluA1 and GluA4 
has a long C-terminus. The estimated single-channel conductance of high-
RI patches were assessed (in which most AMPAR channels were 
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expected to be heteromeric GluA2 containing assemblies) producing a 
single-channel conductance estimates of 6.7 ± 1.0 pS (n = 6) in the 
absence of γ-5 and 14.2 ± 2.2 pS (n = 7; P = 0.0143) in the presence of γ-
5. Thus, expression of γ-5 with GluA2L and GluA4 together gave a 
markedly increased single-channel conductance (Figure 3.2B). The 
possibility that GluA2L itself gives rise to elevated conductance in high-RI 
patches can be excluded, as GluA2/4 and GluA2L/4 receptors both yielded 
very similar conductance estimates in the absence of γ-5. Thus, the 
macroscopic properties of AMPARs may be modified by γ-5, irrespective of 
the presence of edited GluA2, provided the receptors are composed of 
long-form subunits. 
To confirm the selectivity of γ-5 for long form AMPAR subunits rather the 
channels calcium permeability, we compared the effects of γ-5 on the 
unedited (Q) forms of GluA2(Q)s and GluA2(Q)L. As control we compared 
this with the effects of γ-2 on the unedited receptors. As expected, γ-2 
increased the single-channel conductance of both GluA2(Q) (from 19.4 ± 
1.3 to 30.5 ± 3.7 pS, P = 0.0044, n = 10 and 6) and GluA2L(Q) (from 17.7 
± 1.8 to 26.4 ± 2.3 pS, P = 0.0129, n = 7 and 6). We found that γ-5 
increased the conductance of GluA2L(Q) (to 33.0±3.3 pS; P<0.0017, n = 7) 
but produced a significant, although less marked, increase in the 
conductance of the unedited short-form GluA2(Q) (26.1 ± 1.8 pS; P = 
0.0066; n = 8) (Figure 3.2C).  
We also examined the effects of γ-5 on the short-form CP-AMPAR 
composed of homomeric GluA3 and found that although the channel 
conductance of these receptors was increased, this was no less the 
increased conductance of the long-form AMPARs (from 21.7 ± 2.6 to 31.2 
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± 2.7; n = 9 and 12, respectively; Ps = 0.0183) (Figure 3.2E-F). It is also of 
note that γ-2, unlike γ-5, did not increase the Po,peak shown by the 
homomeric GluA2Q (long or short) (Figure 3.2E). This data supports the 
view that the action of γ-5 was preferentially seen with assemblies 
containing the long form subunits, independent of AMPAR calcium 
permeability. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. γ-5 is selective for ‘long-form’ AMPARs. 
(A) tsA201 cells were transfected with GluA4 control, GluA4+γ-5, heteromeric 
GluA2+GluA4 (open circles) or GluAL2+GluA4 (filled circles) with (red) and without 
γ-5 (blue). Outside-out patches were exposed to 10mM glutamate for 100 ms at -
60 mV. The rectification index was obtained by measuring the peak current at +60 
and -60mV. NSFA was used to estimate the single-channel conductance from 
patches expressing a continuum of assemblies from homomeric GluA4 to 
heteromeric short-form GluA2+GluA4 (A) or heteromeric long-form GluA2L+GluA4 
	   70 
(B) with and without γ-5. It is of note that γ-5 increased the conductance of AMPA 
receptor channels when expressed with GluA2L/GluA4 (B); this contrasts with its 
apparent lack of effect when expressed with the GluA4/GluA2 short-form (A).  (C) 
Single-channel conductance for both GluA2(Q) and GluA2L(Q) was increased by 
co-expression with γ-2 or γ-5. (D) Peak open probability (Po,peak) of GluA2(Q) and 
GluA2L(Q) receptors was increased by co-expression with γ-2 but not γ-5. (E) For 
GluA2(Q), RI was altered by γ-2 but not by γ-5, whereas for GluA2L(Q), RI was 
increased both by γ-2 and γ-5. Error bars are SEM (F) Plots of the relationship of 
single-channel conductance of the long-form receptor conductance and Po,peak 
when expressed with γ-5. The long-form receptors GluA1, GluA2L(Q), GluA2L(R) 
+ GluA4 and GluA4 conductance values were elevated when expressed with γ-5 
compared to the heteromeric short-form AMPA combinations containing 
GluA3/GluA4 and GluA2(R)/GluA4 co-expressed with γ−5. The work for this 
figure was carried out in collaboration with David Soto. We each carried out 
equal amounts of work to produce this figure. 
3.3.3. γ-5 regulates cell surface expression of GluA2Q 
Although these results strongly support the idea that γ-5 interacts with all of 
the AMPAR subunits, it predominantly  affects AMPARs receptors 
composed of long-form assemblies. Previous studies have shown that γ-2 
can significantly increase the trafficking of AMPARs to the cell surface 
(Tomita et al., 2005).  It is therefore of interest whether γ-5 might influence 
the trafficking of long-form AMPARs subunits. To address this question, 
cell surface biotinylation experiments were performed on TSA201 cells 
transfected with GluA1, GluA2 short (GluA2s), GluA2L, GluA3 and GluA4 
expressed with YFP-γ or with GFP as a control. For loading controls 
membranes were probed with anti-tubulin antibody. There were no 
differences in the total amount of tubulin protein between GFP and γ-5 
transfected GluA2 receptors.  We found that γ-5 dramatically reduced the 
surface expression of both GluA2s(Q) and GluA2L(Q) (Cell surface control 
GluA2Qs (s) 66% ± 17% to 6% ± 3% for GluA2s(Q) + γ-5 (n = 5, P = 
0.0259*), and cell surface control GluA2QL =82% to 45% for GluA2L 
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(Q)+γ-5  n = 5 P = 0.033) (Figure 3.3C). However, γ-5 had little effect on 
other AMPAR subunits examined. Therefore γ-5-induced decrease in 
surface expression was not solely dependent on AMPAR C-tail length.  
 
 
 
 
 
 
 
 
 
Figure 3.3. The TARP γ-5 controls AMPAR trafficking. 
tsA201 cells were transfected with GluA1, GluA2(Q)short, GluA2(Q)long, 
GluA2(R)short, GluA2(R)long, GluA3 or GluA4. Cells expressing each of these 
AMPA receptor assemblies were co-transfected with either GFP (control) or γ-5. 
(A) Western blot representing the cell surface expression levels of unedited 
GluA2(Q) (left) compared to cell surface expression levels when co-expressed 
with γ-5(right). (B) Western blot representing cell surface expression of edited 
GluA2short in control conditions and co-expressed with γ-5. (C) Cell surface 
expression of GluA2 (Q) short and long receptors was significantly reduced in cells 
co-expressing γ-5 (GluA2(Q)+GFP = 63% percentage of cell surface; GluA2 (Q)+γ-
5 = 5% cell surface), (GluA2L+GFP (Q) = 82%, GluA2L (Q)+γ-5 = 45%) (Input 
refers to the total amount of protein). Pooled data from the biotinylation assays for 
GluA2 (Q), GluA2 (Q) L and GluA2(R) (n = 5 repetitions; P = 0.0259* and P = 
0.033*)  (D) γ-5 does not effect the cell surface expression of GluA1, GluA3 and 
GluA4. Bars are mean average + S.E.M.  
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3.3.4. γ−5 protein is expressed in BGCs  
γ-5 mRNA has previously been identified in BGCs from adult rat brain 
slices (Fukaya et al., 2005). To test the presence of the γ-5 protein 
expression in cultured cerebellar glial cells, cells were cultured from P5 
rats and maintained for 7 days in vitro. Over 80% of cells labelled with an 
antibody against glial fibrillary acidic protein (GFAP), a widely used glial 
cell marker known to be expressed in Bergmann glia (Ango et al., 2008; 
Custer et al., 2006). Once the presence of GFAP expressing astrocytes 
were identified in culture, cells were the labelled with an antibody raised 
against the whole rat γ-5 protein and a secondary anti-rabbit Alexa568 
marker (red). The majority of cultured cells that were labelled with γ-5 
showed the fusiform morphology characteristic of cultured BGCs 
(Burnashev et al., 1992a) (Figure 3.4).  
3.3.5. γ-5 co-immunoprecipitates with native AMPARs 
To establish whether γ-5 was bound to native AMPAR subunits, we 
examined the ability of γ-5 to co-immunoprecipitate with native GluA1 and 
GluA4 in cerebellar cells from P20 rats n = 3. We identified that γ-5 can co-
existed as a complex with GluA1 and GluA4 in cerebellar cells (Figure 3.5 
A-B). To determine whether γ-5 bound to all AMPAR subunits co-
immunoprecipitation assays were performed from HEK 293T cells 
transfected with a yellow fluorescent protein (YFP)–γ-5 and AMPAR 
subunits. We also investigated if γ-5 bound to long and short GluA2. These 
experiments revealed that γ-5 protein complexes with both GluA2(Q) and 
GluA2L(Q) n = 3 (Figure 3.5C). This is consistent with the view that γ-5 
interacts with all AMPAR subunits, but that it modulated predominately 
functional properties of the long-form AMPARs subunits. 
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Figure 3.4. The TARP γ-5 is expressed in cultured fusiform glia from the 
cerebellum. 
(A) Cultured cerebellum glial cells (days in vitro, (DIV7)) from P7 rats were 
labelled with rabbit anti-γ5. DIC images (middle panel) revealed fusiform glia 
labelled with γ-5. (D) To identify astrocytes in cerebellar cultures, cells were 
labelled with rabbit anti-GFAP.  
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Figure 3.5. The TARP γ-5 interacts with native and recombinant AMPAR 
subunits. 
(A-B) Western blots demonstrated the interaction of γ-5 with native GluA1 and 
GluA4 from rat cerebellum. P20 rat cerebellum was homogenised, initially a 
proportion of the cerebellum lysate was denatured using SDS (95 °C). This was 
used to determine the total amount of GluA1 and GluA2 expressed in the 
cerebellum (A, input). The remaining lysate was incubated with antibody against γ-
5, which binds to the native γ-5 protein. To determine the specificity of the γ-5 
association with AMPA receptors, the cerebellar lysate was also incubated with a 
non-immune antibody control (IgG). The membrane was probed with anti-GluA1  
(A) and anti-GluA4 antibodies (B). (C) YFP-tagged γ-5 (YFP–γ-5) was transfected 
into tsA201 cells together with either GluA(Q)2 or GluA2L (Q). Both GluA(Q)2 and 
GluA2L (Q) co-immunoprecipitated with γ-5. YFP–γ-5 protein complexes were 
immunoprecipitated (IP) with anti-GFP and subjected to Western blotting with 
input samples and the IgG controls using the anti-GluA2 antibody. The nearest 
molecular weight marker is indicated. 
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3.3.6. γ-5 regulates AMPARs involved in neuronal-glial 
signalling 
BGC AMPARs are activated by release of glutamate from climbing and 
parallel fibres in the cerebellum (Clark et al., 1997). Previous experiments, 
using double immunogold labelling, have shown that the scaffolding 
protein SAP97 (synapse-associated protein-97) is associated with GluA1 in 
the BGC plasma membrane directly facing parallel fibre terminals (Douyard 
et al., 2007). Is γ-5 important for neuronal-glial communication in BGCs? 
To determine whether γ-5 is present in a complex with SAP-97 I used co-
immunoprecipitation assay from cerebellar tissue from the adult rats. 
These experiments revealed an interaction of SAP97 with both GluA1 and 
γ-5 in the cerebellum (Figure 3.6A). Fukaya et al., (2005) has shown that 
γ-5 mRNA expression in the cerebellum is restricted to BGCs, and as SAP-
97 is also present in these cells at points of contact between CF-PFs and 
BGCs, our experiments suggest that BGC AMPARs at these contact sites 
are associated with γ-5.   
Previous studies have revealed the presence γ-4 and γ-5 mRNA in BGCs 
(Fukaya et al., 2005). To determine whether γ-5 or γ-4 is the predominant 
TARP regulating BGC AMPAR responses, we next examined the 
published values for the decay of BGC quantal events (Matsui et al., 2005) 
and compared the published values with the deactivation kinetics of the 
recombinant receptors GluA4 and GluA1 expressed with and without 
TARPs γ-4 and γ-5. In accord with our co-immunoprecipitation data 
suggesting that SAP-97 and γ-5 formed complexes with AMPARs in BGC 
as the decay of quantal events matched well with the deactivation kinetics 
of receptors co-expressed with γ-5 (Figure 3.6B). Of note, the time 
constant for the deactivation of GluA1 or GluA4 receptors expressing γ-4 
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was more than five times that of the decay of BGC quantal events (Figure 
3.6C). These results therefore support the view that suggesting that the 
properties of AMPARs involved in neuronal-glial signalling in BGCs are 
regulated by γ-5. 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. γ-5 is associated with transmitter activated AMPARs in BGCs. 
(A) Western blot demonstrating co-immunoprecipitation of γ-5 with SAP97 in the 
rat cerebellum. Protein extracted from the adult rat cerebellum was incubated with 
either an antibody to γ-5 or an antibody to GluA1 or control IgG. (B) 
Representative averaged current responses after the application of glutamate (1 
mM, 1 ms, -60 mV) to outside-out patches taken from tsA201 cells transfected 
with GluA1 or GluA4 AMPAR subunits co-expressed with γ-4 or γ-5. (C) 
Deactivation kinetics of GluA1 and GluA4 co-transfected with either γ-4 (grey) or γ-
5 (black) in comparison to the quantal EPSC τ decay BGCs kinetics (dashed 
lines). The deactivation kinetics of GluA1 and GluA4 + γ-5 match closely with τ 
decay values for BGC qEPSC (dashed lines) (error bars are s.e.m). BGC 
AMPARs deactivation data taken from Matsui and Jahr (2006). 
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3.3.7. In olfactory bulb and spinal γ-5 is selectively expressed in 
astrocytes 
TARPs are expressed in various neurons and glia throughout the central 
nervous system. TARPs γ-2, γ-3, γ-4, γ-7 γ-8 have been previously 
identified in neurons, such as cerebellar granule cells (γ-2) and 
hippocampal neurons (γ-8) (Chen et al., 2000; Tomita et al., 2003 Rouach 
et al., 2005). Furthermore, γ-4 has been identified in both neurons and 
astrocytes in the CNS (Tomita et al., 2003). However so far none of the 
TARPs (γ-2, γ-3, γ-4, γ-7 and γ-8) appear to regulate AMPARs in glia. γ-5 
mRNA, which appears to be expressed in Bergmann glia in the 
cerebellum, is also expressed in the olfactory bulb of P7 rats. To obtain 
further insight into whether γ-5 is selectively expressed in glial cells, 
neuron-glia co-cultures were generated from the olfactory bulb and the 
spinal cord of E17 rats. Neurons were identified with an antibody against 
the neuronal microtubule-Associated Protein-2 (anti-MAP2), and glial cells 
were identified with an antibody against GFAP. The majority of co-cultures 
from the olfactory bulb and the spinal cord contained both MAP2-positive 
cells and GFAP-positive cells. In these cultures, the γ-5 was generally 
located to non-neuronal MAP2-negative cells, which had morphologies 
similar to that of GFAP positive astrocytes (Figures 3.7 & 3.8).  
Previous studies have shown that in the cerebellum γ-5 does not co-
immunoprecipitate with the postsynaptic density protein PSD-95, which is 
expressed at high levels in neurons (Kato et al., 2007). However as 
described above, in the cerebellum we find that γ-5 is in a complex with 
SAP-97, a protein highly enriched in glia. This observation appears to be 
consistent with the idea that γ-5 may be a glial specific-protein.
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Figure 3.7. γ-5 is prominently expressed in non neuronal cells in the 
olfactory bulb . 
(A) Mixed neuronal-glial cultures were obtained from P7 rat olfactory bulbs. Cells 
were labelled with rabbit anti-γ−5 (red) DIC image (middle) reveals high levels of 
expression in cells with astrocytic morphology, however cells with neuronal 
morphology are devoid of γ-5 expression. (B) γ-5 is not expressed in MAP2 
positively labelled neuronal cells (green). In the overlay image, note the presence 
of γ-5 labelling in the large flat astrocytic cell (black arrow) and the absence of γ-5 
expression in a neuronal MAP2-positive cell (white arrow) evident in the DIC 
image (lower panel). (C) Neuronal-astrocyte cultures were fixed and labelled with 
anti-γ-2,γ-3,γ-4,γ-8 (pan-TARP) (red). DIC images of neuronal-glial cultures 
labelled with pan-TARP antibody (red). Note the contrast in the expression 
patterns of the TARP γ-5 as seen in middle image of panel A, and the expression 
pattern of cell labelled with pan-TARP antibody (image C) (γ-2,γ-3,γ-4 and γ-8) as 
these proteins are expressed in cells with neuronal morphologies in contrast to γ-
5.  (Scale bar 25µM).  
 
 
 
 
 
Figure 3.8. Glia in spinal cord express γ-5. 
Spinal cord spiny neurons were grown on an astrocyte feeder layer. Neuronal-glial 
cultures were harvested from E15 rat embryos after six days in vitro. Cultures 
were labelled with rabbit anti-γ-5 (A) and anti-MAP2 (B). As is apparent from the 
overlay image, γ-5 labelling is predominant in astrocytes taken from e spinal cord. 
A very low level of expression was detected in spiny neurons (n=22 cells).  
3.3.8. γ-5 decreased GluA2(Q) expression via the lysosomal 
pathway 
The data described in section 3.3.3 suggested that the cell surface level of 
GluA2(Q) was decreased in the presence of γ-5. There are three possible 
explanations for this observation (1) GluA2(Q) was retained at the 
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endoplasmic reticulum or (2) GluA2(Q) was rapidly removed from the cell 
surface and sequestered in early endosomes, or (3) binding of γ-5 to 
GluA2(Q) initiates targeting of the receptor to the late endosomes or 
lysosomes for subsequent degradation. To determine which of the 
mechanisms could account for effects of γ-5 on GluA2(Q), we examined 
the localisation of γ-5 in cultured olfactory bulb astrocytes. Initially we 
investigated whether γ-5 was present in the endoplasmic reticulum (ER) by 
labelling cells with an anti-γ-5 antibody and an anti-protein disulphide 
isomerase marker (a protein expressed in the ER). In the majority of 
olfactory bulb glia, γ-5 and PDI did not appear to co-localise, suggesting 
that γ-5 was not retained in the ER. To examine whether γ-5 was localised 
in the early endosome, cells were labelled with the antibody for EEA1 a 
marker for early endosome, together with an anti-γ−5 antibody. There was 
no apparent co-localisation between γ-5 and the early endosome. (Figure 
3.9). We next investigated whether this reduction was due to the 
degradation of GluA2(Q), we investigated whether γ-5 was significantly 
localised in the late endosomal pathway and hence, whether reduced 
surface expression of GluA2(Q) reflected degradation. The tSA201 cells 
were transfected with GFP-γ-5 and the late endosomal marker CD63. The 
co-localisation rate was calculated by comparing the percentage of overlay 
between the fluorescence of the GFP-γ-5 and CD63 using LEICA 
microscope co-localisation software. There was 63% co-localisation of γ-5 
and the late endosome marker, strongly suggesting that γ-5 was targeting 
receptors in the lysosomes. To further address whether γ-5 was targeting 
GluA2(Q) to the lysosomes we performed cell surface biotinylation 
experiments in the presence of the lysosomal protease inhibitor leupeptin. 
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In the presence of this protease inhibitor, the cell surface levels of 
GluA2(Q) recovered to control levels (Figure 3.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. γ-5 does not co-localise with the early endosome or the 
endoplasmic reticulum in glia. 
(A) Olfactory bulb glia (DIV12) were labelled with anti-γ-5 and the early endosome 
marker EEA1 (n = 28 cells). From the overlay image shown in image A, γ-5 does 
not appear to overlap significantly with the early endosome (P = 0.16). (B) Glial 
cells were labelled with a mouse anti-PDI (marker for the ER) and γ-5. The 
distribution of γ-5 did not overlay with the distribution of PDI (n=15) (Scale 25µm).  
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Figure 3.10. TARP γ-5 co-localises with the late endosome marker CD63. 
(A) TSA201 cells were transfected with GFP tagged γ-5 (middle panel) and 
permeabilized with 0.5% Triton 24 hrs post-transfection. Cells were labelled with 
an anti-CD63 (right-hand panel) (n=30 cells). From the overlay image, co-
localisation is apparent. The overlay of γ-5 and CD63 was 63%, which suggests 
that a proportion of the TARP resides in the late endosome pathway (co-
localisation was analysed using Leica microscope co-localisation software). (B) 
Cells were transfected with GluA2(Q) and GFP, or with GluA2(Q) and γ-5. Cells 
transfected with GluA2 (Q) + γ-5 were incubated with 100 µM of the protease 
inhibitor leupeptin for 1 hour at 37°C to (n=3). Cell-surface biotinylation was 
performed to determine the percentage of surface GluA2(Q), when cells were co-
transfected GluA2 (Q) with γ-5 and then treated with the protease inhibitor 
leupeptin. The application of leupeptin significantly prevented the loss of cell 
surface GluA2Q when expressed with γ-5. Bars in left hand panel of B are the 
mean values +/- S.E.M. P<0.05* 
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3.4. Discussion 
3.4.1. γ-5 is a functional TARP 
The experiments in this chapter suggest that γ-5 is behaving in some 
respects to TARP family members as it interacts with AMPARs and altering 
the trafficking and channel properties. However, unlike other TARPs, γ-5 
exhibits selectivity for long-form AMPARs, the majority of which are 
calcium permeable. The results also show that γ-5 expression is largely 
restricted to non neuronal cells in a number of brain regions.  
3.4.2. γ-5 is selective for long-form AMPA receptors 
These experiments have established that γ-5 is a TARP, but that it displays 
a number of unique properties. In particular (1) increasing the channel 
conductance of the long-form subunits (GluA1 and GluA4) (2) decreasing 
the surface expression of AMPARs containing GluA2(Q) and (3) 
decreasing the channel open probability. 
As most long-from AMPAR subunits in the CNS form CP-AMPARs, γ-5 
modified predominately CP-AMPARs. The unique property of γ-5 could be 
attributed to differences in the amino acids, present in the C-terminus 
compared with the other identified TARPs. The TARPs γ-2, γ-3, γ-4 and γ-8 
contain the PDZ-binding region -TTPV, which is responsible for interaction 
with PSD-95 and the clustering AMPARs at the synapse (Bats et al., 
2007). However, the C-terminus of γ-5 expresses the amino acids –SSPC. 
This could interact with a different class of PDZ-binding proteins. Using a 
yeast two-hybrid screen against the C-terminus of the TARPs γ-2, γ-3, γ-4, 
γ-5, γ-7 and γ-8, Deng et al., (2006) demonstrated that, although  γ-2, γ-3, 
γ-4, and γ-8 bind to PSD-95 and MAG-1 (membrane-associated guanylate 
kinase), neither γ-5 nor γ-7 can bind to these proteins, suggesting that they 
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may interact with distinct protein partners.  
A further possible explanation for the unusual behaviour of γ-5 could be 
that it has an exceptionally short C-terminus and, consequently, it lacks of 
all but two of the ten-phosphorylation sites present in the C-terminus of 
other TARPs. Because these sites are involved in the regulation of AMPAR 
trafficking, it seems likely that these differences between TARPs could 
influence differential receptor regulation. 
3.4.3. γ-5 has unique effects on cell surface AMPARs 
The current experiments indicate an interesting feature of γ-5 in its ability to 
act as a suppressor of AMPARs cell surface expression.  This reduction is 
selective for the calcium permeable short-form of GluA2 (GluA2(Q)). It 
would be interesting to perform a yeast-two hybrid screen against the N-
terminal and C-terminal domains of γ-5 for proteins that are responsible for 
targeting the protein to the late endosomes.  
3.4.4. γ-5 regulates AMPARs involved in neuronal-glial 
signalling  
Within the cerebellum, only BGCs express γ-5 mRNA (Fukaya et al., 
2005). These cells are known to express CP-AMPARs, which are activated 
during neuronal–glial signalling and are crucial for the maintenance of 
normal synaptic transmission from parallel and climbing fibres to Purkinje 
cells (Iino et al., 2001). Despite the importance of AMPARs in neuron–glia 
interplay, it was previously unknown whether TARPs influence the 
trafficking, anchoring or functional properties of AMPARs in glia. Current 
experiments indicate that CP-AMPARs in these BGCs have properties that 
match those shown by recombinant γ-5-associated AMPARs. The plasma 
membrane of BGCs that directly faces sites of ectopic glutamate release 
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from climbing and parallel fibres contains both SAP97 and GluA1 receptor 
subunits. 
Previous studies have shown that γ-5 does not interact with PSD-95 (a 
protein highly enriched in neurons), suggesting that the γ-5 is absent in 
neuronal synapses (Kato et al., 2007). Because γ-5 in the cerebellum is 
restricted to BGCs, our finding that the γ-5 antibody pulled down SAP97 
supports these previous observations. (Douyard et al., 2007) Together, our 
data suggest that γ-5 is associated with AMPARs in the BGC membrane 
directly opposed to presynaptic terminals and that it determines the 
properties of the CP-AMPARs underlying neuron–BGC signalling. 
Furthermore, the continuous activation of BGC CP-AMPARs by glutamate 
released from climbing and parallel fibres has been reported to be 
essential for the maintenance of connections to Purkinje cells (lino et al., 
2001). 
 
 
 
 
 
 
 
Figure 3.11. Hypothetical comparison of TARP-AMPAR interaction at 
neuronal synapses vs neuronal glial junctions. 
γ−2 has been shown to interact with PSD-95 and with GluA2/GluA4 heteromers at 
neuronal synapses, in comparison to γ-5, which forms a complex with 
GluA1/GluA4 heteromers and with SAP-97 in Bergmann glia cells. 
	   86 
3.4.5. γ-5 is unique to glia in several brain regions 
In this chapter we have shown that γ-5 present in the cerebellar, olfactory 
bulb, and spinal cord, where it could influence AMPAR-mediated calcium 
entry. The inability of γ-5 to ‘rescue’ AMPAR responses in TARP-lacking 
cerebellar granule cells from stargazer mice is entirely consistent with our 
findings. Granule cells express predominantly short-form AMPAR subunits 
(GluA2 and GluA4c). We found only a small increase in channel 
conductance when GluA2/GluA4 heteromers were co-expressed with γ-5. 
This is consistent with the fact that γ-5 did not enhance AMPAR surface 
expression, in cerebellar granule cells, suggests that γ-5 would be unlikely 
to alter the macroscopic current of short-form containing AMPARs.  
A recent study published by (Kato et al., 2008) also shows that γ-5 is a 
TARP with subunit selectivity. However, the conclusions produced from 
theis study differs notably from the present work in this chapter as it argues 
that; (i) only GluA2-containing AMPARs are regulated by γ-5, (ii) this 
specificity depends on editing at the Q/R site of GluA2, and finally (iii) γ-5 
does not control the receptor trafficking or surface expression of AMPARs. 
Although we found, in one case (homomeric GluA2 AMPARs), that γ-5 had 
apparent editing-dependent effects, these recent findings contrast with our 
main conclusion that γ-5 interacts with all AMPAR subunits and, to varying 
extents, modifies their properties. In the present study, the predominant 
functional effect of γ-5 was on long-form AMPARs, which, with the 
exception of the splice variant GluA2L, are calcium permeable. This 
selectivity of γ-5 of that I have described was not dependent on the Q/R 
editing state. The presence and function of γ-5 in BGCs, a cell type that 
expresses only CP-AMPARs, seems inconsistent with the view that this 
TARP affects only GluA2-containing AMPARs.  
	   87 
Chapter 4. ATP and glutamate mediate TARP 
dependent AMPAR bidirectional plasticity in 
oligodendrocyte lineage cells  
4.1. Summary  
Oligodendrocyte precursor cells (OPCs) are a major glial cell type in the 
CNS. These cells express a mixture of calcium permeable and calcium 
impermeable AMPARs, as well as phospholipase C linked G-protein 
coupled group I mGluRs and purinergic P2Y receptors (Itoh et al., 
2002;Luyt et al, 2004). Initially we examined whether activation of mGluRs 
in optic nerve OPCs can mediate AMPAR plasticity, similar to that 
previously described in the cerebellar stellate cells synapses where 
mGluR1 activation drives the loss of calcium permeable AMPARs. However 
in striking contrast to mGluR response in stellate-cell interneurons the 
activation group I mGluR in OPCs promoted an increase the proportion of 
calcium permeable AMPARs.  
This plasticity in OPCs was independent of CamKII and utilized kinases 
similar to that used to control mGluR dependent cerebellar LTD. We also 
investigated whether mGluR mediated AMPAR plasticity could be induced 
in mature pre-myelinating OPCs, and found a decrease in mGluR mediated 
AMPA plasticity in these cells.  
Neurons and astrocytes in the white matter have been shown to release 
ATP along with glutamate onto OPCs stimulating an increase in 
intracellular calcium in these cells (Hamilton et al., 2010; Porter and 
McCarthy, 1996; Wang et al., 2000; Zhang et al., 2003). Our experiments 
suggest that activation of purinergic receptors can also regulate the relative 
proportions of calcium permeable AMPAR. Finally our experiments show 
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that the transmembrane AMPA regulatory protein stargazin (γ-2) regulates 
AMPAR properties in OPCs, and that the PDZ binding domain of γ-2 is 
critical for mGluR-mediated AMPA plasticity in these cells.  
4.2. Introduction  
Oligodendrocytes are the major myelinating cells in the mammalian CNS.  
These cells derive from oligodendrocyte precursor cells (OPCs) that arise in 
spatially restricted regions of the ventricular zone (Noble, 2000; Rogister et 
al., 1999). 
Native OPCs derived from the optic nerve express a variety of receptors 
including calcium permeable-AMPARs, also expressed in a primary OPC 
cell line (CG4), which can also fully differentiate into oligodendrocytes 
(Pende et al., 1994). Glutamate has been shown to potentiate the 
expression of immediate early genes, and influence OPC proliferation and 
migration (Gudz et al., 2006; Pende et al., 1994) Furthermore, activation of 
CP-AMPARs in these cells has been linked to an increased risk of their 
apoptosis after acute periods of hypoxia (Alberdi et al., 2002).  
Bergles et al., (2000) provided evidence that CP-AMPARs expressed on 
OPCs are activated by glutamate released from CA1 hippocampal neurons. 
This release of glutamate from neurons onto OPCs can induce AMPAR 
plasticity in the hippocampus producing an increased expression of CP-
AMPARs (Ge et al., 2006). Although the mechanisms underlying this 
change are unknown it is interesting that OPCs are also know to express 
mGluRs receptors providing a potential mechanism for controlling AMPAR 
plasticity in OPCs. The experiments described in this chapter demonstrate 
that activation of mGluRs and P2Y receptors can give rise to a form of 
bidirectional plasticity in OPCs, our experiments also suggest that the 
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TARP γ-2 is expressed in OPCs, and is involved in the mGluR mediated 
AMPAR plasticity in these cells.  
4.3. Results  
4.3.1 mGluR activation decreases AMPAR channel rectification 
in CG4-OPCs 
To examine whether mGluR activation might alter the proportion of GluA2-
containing CP-AMPARs in OPCs, we examined glutamate-evoked whole-
cell current-voltage (I-V) relationships in CG4 OPCs (an OPC cell-line). We 
assessed the presence of GluA2-lacking CP-AMPARs from the voltage-
dependent block produced by added intracellular spermine (100 µM). In 
these experiments, the agonist solution contained 100 µM glutamate plus 
50 µM cyclothiazide to prevent AMPAR desensitization. We first tested 
whether CG4 cells generate rectifying responses that could be blocked by 
the AMPAR antagonist GYKI 52466 dihydrochloride (50 µM) (Figure 4.1). 
In control untreated cells, the I-V relationships (–100 to +60 mV) showed 
modest rectification, with a mean rectification index (RI, see Methods) of 
0.68 ± 0.04, n = 6) indicating a mixture of calcium permeable and calcium 
permeable AMPARs present at the cell surface of in CG4 OPCs (Fig. 
4.2A). Having shown the presence of CP-AMPARs in these cells we next 
examined the effects of group 1 mGluR (mGluR1/5) selective agonist (S)-
3,5-dihydroxy-phenylglycine (DHPG, 100 µM; 30 minutes at 37°C). 
Following mGluR activation the I-V relationships became more rectifying 
(Figure 4.2B), with RI reduced to 0.33 ± 0.05, n = 10; P = 0.0006***).  
mGluR induced decrease in AMPAR rectification index was reduced with 
mGluR5 antagonists ACDPP applied together with the group I/II mGluR 
antagonist MCPG (RI = 0.055 ± 0.04 P= 0.08 compared to control RI). This 
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change in rectification is consistent with an increase in the proportion of 
CP-AMPARs following DHPG treatment (Figure 4.2D). At negative 
potentials (–100 mV), where CP-AMPARs are relatively unaffected by 
polyamine block (Bowie and Mayer, 1995; Soto et al., 2007), DHPG 
application increased the current density from 64.1 ± 15 pA/pF to 158.1 ± 
31 pA/pF (n = 10 and n = 10; P = 0.00016). Such an increase could reflect 
a simple increase in receptor number, but would also be consistent with 
the higher single-channel conductance of CP-AMPARs compared with 
calcium impermeable-AMPARs (Feldmeyer et al., 1999; Mameli et al., 
2007). The current density increase produced by DHPG could be 
prevented by application of a mixture of mGluR blockers ACDPP (10 µM) 
and MCPG  (500 µM) (Figure 4.2D). The current density in the presence 
of DHPG+MCPG+ACDPP was 83.3 ± 16.22 pA/pF were not significantly 
different from control values (n = 6; P = 0.09). 
 
 
 
 
 
 
 
Figure 4.1. Glutamate activates AMPARs in CG4 OPCs. 
(A) Out-side out patches pulled from CG4 OPCs cells were exposed to 100µM 
glutamate for 100ms, activating AMPARs, which was blocked with the application 
of 50µM GYKI 52466. (B) Whole-cell AMPAR current ramps in response to 
glutamate were blocked by GYKI 5246. 
. 
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Figure 4.2. Group I mGluR agonist DHPG increases the proportion of 
calcium permeable AMPARs in CG4 OPCs.  
(A-B) Typical example of whole-cell I-V AMPAR responses (+60mV to -100mV) 
from control cells and cells treated with the 100µM of the mGluR agonist DHPG, 
(C-D) Averaged whole-cell ramp I-V responses to bath application of	   100µM 
glutamate from control cells (n = 6), and DHPG treated cells (n = 10). DHPG 
treated cells had an inwardly rectifying response and a significantly reduced 
Rectification Index (current amplitude at +60mV/-60mV); (Control RI= 0.68 ± 0.04, 
DHPG treated cells RI= 0.33 ± 0.05; n = 6 and n = 10; P = 0.0006**). (D) The 
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mGluR antagonist ACDPP (10µM) together with MCPG (500µM) blocked the 
DHPG induced reduction in RI (ACDPP+MCPG+DHPG, RI= 0.55 ± 0.04;n = 6). (E) 
DHPG increases the current density of AMPAR responses compared with control 
levels (control 64.1 ± 15 pA/pF n = 10; DHPG 158.1 ± 31 pA/pF n = 10 and P 
=0.00016***). The effects of DHPG on AMPAR current density was blocked by 
application of the mGluR antagonists ACDPP and MCPG (83.38 ± 16.22 n = 6) *** 
Denotes significant difference from control, D. Mean data and error bars represent 
S.E.M. 
 
4.3.2. mGluR activation increases AMPAR channel conductance 
in CG4 cells 
As discussed above, if DHPG treatment does indeed increase the 
proportion of CP-AMPARs in CG4 OPCs, one would expect an increase in 
the AMPAR single-channel conductance. To test this, we recorded 
currents from outside-out membrane patches (–60 mV) in response to 
rapid application of 10 mM glutamate (100 ms) and used non-stationary 
fluctuation analysis (NSFA; see Methods) to determine the weighted 
mean single-channel conductance and the peak open probability (Po, peak). 
DHPG treatment produced a significant increase in single-channel 
conductance (Control 29 ± 2.3pS to DHPG 46 ± 4pS;n = 14 control and n = 
11 DHPG; P = 0.0008) that was blocked by treatment with mGluR 
antagonists MCPG and ACDPP (35.2 ± 4.4 pS; n = 5, P = 0.29 compared 
to control) (Figure 4.3D). Po, peak and the time course of desensitization 
were not significantly affected by mGluR activation (Figure 4.3E-F).  
Together the change in RI and single channel conductance suggest that 
activation of group I mGluRs in CG4 OPCs is producing an increase in the 
proportion of CP-AMPARs. This DHPG-induced change in AMPAR 
properties differs strikingly from that recently described in dopaminergic 
cells of the ventral tegmental area (that express CP-AMPARs following 
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cocaine treatment) (Mameli et al., 2007) and in molecular layer 
interneurons of the cerebellar cortex (Kelly et al., 2009). In these cases 
mGluR activation causes a decrease in the proportion of CP-AMPARs. 
Although these neuronal changes may differ in their details, they are both 
distinct from mGluR-induced long-term depression (LTD) seen in 
hippocampal CA1 cells and LTD at parallel fiber–Purkinje cell synapses 
(Moult et al., 2006; Xiao et al., 2001; Zakharenko et al., 2002) and instead 
reflect changes in protein synthesis and/or intramembrane movement of 
receptors, consequent upon elevation of intracellular calcium ([Ca2+]i).  
4.3.3. DHPG-induced AMPAR changes require Ca2+ elevation  
We next investigated potential mechanisms that might contribute to the 
mGluR-induced AMPAR changes in CG4 OPCs, by examining the effects 
of various treatments on the ability of DHPG to alter either RI or channel 
conductance. In OPCs, DHPG is known to increase intracellular [Ca2+]I, 
that is prevented by pretreatment with the selective mGluR antagonists 
MCPG and ACDPP, and results from inositol 1,4,5-trisphosphate (IP3)-
mediated Ca2+ release from intracellular stores (Luyt et al., 2003). To 
determine whether such Ca2+ elevation might trigger the AMPAR changes 
we observed, we incubated CG4 OPCs with the membrane-permeable 
Ca2+ chelator BAPTA-AM (20µM) with DHPG. Following such treatment, 
the effect of DHPG on AMPAR channel single-channel conductance was 
suppressed (34.9 ± 5.0 pS; n = 9; P = 0.36 compared to control) (Figure 
4.3D). 
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Figure 4.3. mGluR activation increases single-channel conductance of 
AMPARs in CG4 cells. 
(A-B) Average responses to fast application of 10mM glutamate (100ms, -60mV) 
onto outside-out patches from control and cell treated with DHPG. Control currents 
are the mean of 80 traces; DHPG treated current is the mean of 110 traces. Insets 
show plots of noise variance vs. inward current. (C) Pooled current variances 
parabolas from control and DHPG treated cells. (D) The estimated mean single-
channel conductance increased from control 29 ± 2.3 to DHPG treated 46 ± 4pS (P 
= 0.0008**). The mGluR mediated increase in single-channel conductance was 
blocked by the addition of the antagonists ACDPP and MCPG (35.2 ± 4.4 pS; n = 
5, P = 0.29 compared with control). BAPTA-AM also blocked the rise in single 
channel conductance (single channel conductance = 34.9 ± 5.0pS P = 0.3 
compared to control). (E-F) mGluR activation did not significantly increase AMPAR 
channel Po,peak nor alter AMPAR desensitization kinetics (control Po,peak = 0.68 ± 
0.05; following DHPG treated = 0.73 ± 0.04; control τdes = 5.77ms; following DHPG 
treatment τdes = 4.39ms).  
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4.3.4. mGluR induced AMPAR plasticity is dependent on PICK-
1, PI3K and protein synthesis 
mGluRs mediated AMPAR plasticity in neurons has been linked to the 
activation of several key intracellular pathways that are regulated by 
phosphatidylinositol 3-kinases (PI3-K), c-Jun N-terminal kinases-3 (JNK-3) 
and protein interacting with C-kinase-1 (PICK-1) (Hou and Klann, 2004; Jo 
et al., 2008; Li et al., 2007).  We therefore wanted to examine whether in 
mGluR-induced AMPA plasticity in CG4 cells was also dependent on these 
intracellular pathways.  
In this study we first examined the PI3K-Akt-mTOR pathway, which has 
been shown to trigger an increase in local protein synthesis of GluA2, in 
response to mGluR1 activation in VTA neurons and stellate cell 
interneurons. This increase in protein synthesis was subsequently blocked 
by protein synthesis inhibitor cyclohexamide (C-hex) (Mameli et al, 2007; 
Kelly et al., 2009). To examine whether the mGluR induced decrease in 
AMPAR rectification in CG4-OPCs is dependent on the activation of PI3K 
and local protein synthesis, cells were treated with either 25µM C-hex or 
with the PI3K inhibitor wortmannin (co-applied with 100µM DHPG) for 30 
minutes (Figure 4.4B). C-hex and wortmannin significantly reduced the 
effect of DHPG activation on AMPAR rectification, providing evidence that 
newly formed CP-AMPARs are required for mGluR-induced AMPAR 
plasticity in CG4 cells (Control RI = 0.60 ± 0.055, C-hex + DHPG RI = 
0.66 ± 0.08, wortmannin+DHPG= RI = 0.5 ± 0.039).  
Next we examined whether the protein PICK-1 was involved in mGluR 
plasticity in CG4 cells. PICK-1 has been previously linked with mGluR 
induced internalisation of AMPARs in the perirhinal cortex (Jo et al., 2008). 
To test whether mGluR activation in CG4s triggers PICK-1 to internalize 
GluA2, the selective cell-permeable PICK-1-GluA2 blocking peptide TAT-
	   96 
pep2-EVKI (25µM) was used. Cells were treated with a selective cell-
permeable PICK-1 inhibitor peptide (25µM) together with 100µM DHPG. 
PICK-1 inhibitor peptide significantly inhibited the effect of DHPG, 
suggesting that activation of mGluRs is trigger internalisation of GluA2 via 
activation of PICK-1. (PICK-1 + DHPG RI = 0.66 ± 0.04; n = 7, P = 0.6 
compared with control) (Figure 4.4A).  
NMDA-induced LTD in CA1 hippocampal neurons has been shown to be 
dependent on CamKII (Leonard et al., 1999, Lee et al., 2009). Currently no 
studies have reported whether mGluR mediated AMPAR plasticity could 
be dependent of activation of CamKII. To address this CG4 cells were 
treated with KN-62, a cell permeable blocker of CamKII. KN-62 failed to 
block the mGluR-induced reduction in AMPAR rectification in these cells 
(KN-62 RI = 0.4 ± 0.05; n=7, P = 0.001*), demonstrating that in CG4 the 
activation of mGluR is independent on CamKII (Figure 4.4C).  
Finally I examined the role of the kinase JNK (JNK1-3), which are activated 
by glutamate binding to mGluRs.  In recent studies Ahn et al (2009) 
demonstrated that the activation of group I mGluRs in the dorsal striatum 
leads to an increased phosphorylation of GluA2, which was be blocked 
with the application of cell permeable JNK antagonist (SP600125). 
(Thomas et al., 2008) has also shown that in neurons JNK-3 is responsible 
for the recycling of a long variance of GluA2. To examine whether JNK 
activation in CG4 cells controls AMPAR plasticity, cells were treated with 
the JNK antagonist SP600125 (100µM) together with DHPG (100µM). The 
blockade of JNK significantly reduced mGluR mediated AMPAR plasticity 
in CG4 (SP600125 RI= 0.6 ± 0.08 compared with control; n=8, P = 0.71) 
(Figure 4.4A). These results suggest that mGluR induced AMPAR 
plasticity in required activation of PI3K, PICK-1 and JNK-3 in CG4 cells.  
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Figure 4.4. mGluR induced AMPA plasticity is dependent on intracellular 
kinases and protein synthesis. 
Protein synthesis inhibitor cyclohexamide (C-hex) and PI3K inhibitor wortmannin  (n 
= 7) or anti-PICK-1 peptide (20µM) (n = 7) suppressed mGluR induced change in 
rectification (Control RI = 0.60 ± 0.055, RI = C-hex + DHPG RI = 0.66 ± 0.08 P = 
wortmannin+DHPG = RI = 0.5 ± 0.039). JNK inhibitor SP600125 (n = 8) also 
perturbed the effect of DHPG on AMPA receptor rectification (SP600125, RI = 0.6 ± 
0.08 compared to control P = 0.71) (Anova Kruskal-Wallis rank sum test). However, 
the CamKII inhibitor KN-62 failed to block DHPG induced decrease in rectification: 
RI = 0.4 ± 0.05 (P = 0.001*). 
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4.3.5. mGluR induced AMPAR plasticity in optic nerve OPCs is 
developmentally regulated  
In the previous sections we focused on mGluR mediated AMPAR plasticity 
in CG4 cells. It was of importance to determine whether mGluR mediated 
AMPA plasticity was present in native OPCs. In this study we used purified 
OPCs from optic nerve, as this region contains a high density of OPCs 
whilst being devoid of neuronal cell bodies. Initially we examined whether 
mGluR-mediated AMPAR plasticity in native OPCs using DHPG. The 
AMPAR rectification was obtained using whole-cell I/V plots in response to 
glutamate. Consistent with CG4 cells, the activation of mGluRs in immature 
OPCs induced a reduction in AMPARs rectification index (Control RI = 0.7 
± 0.04 DHPG RI = 0.47 ± 0.02; Control n = 13, DHPG n = 13; P = 0.006*) 
(Figure 4.5B). 
During development OPCs undergo differentiation into myelinating 
oligodendrocytes. During this differentiation, there are significant alterations 
in the receptor expression levels followed by an increase in the number of 
process formed (Dugas et al., 2010). It is possible to regulate the 
development of OPCs in vitro with the addition of the growth factors: 
platelet-derived (PDGF) and basic fibroblast (bFGF) that maintain OPCs in 
an immature phase. However the removal of mitogens and the addition of 
thyroxine to the OPC growth media triggers differentiation of the cells into 
pre-myelinating OPCs followed by reduced expression of GluA3 mRNA 
(Itoh et al., 2002; Temple and Raff, 1986). Similarly there are reductions in 
the expression of mGluR5 in mature pre-myelinating CG4 cells (Luyt et al., 
2006). To assess whether mGluR plasticity is also present in 
premyelinating cells, we examined the AMPAR rectification in response to 
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glutamate after treating cells with DHPG. We also examined whether there 
were alterations of AMPAR channel properties during OPC differentiation 
into pre-myelinating cells. The AMPAR rectification index of pre-myelinating 
OPCs was larger compared to immature OPCs, suggesting a reduction of 
CP-AMPARs during differentiation of OPCs (immature OPC RI = 0.7 ± 0.04 
n = 19, Pre-myelinating OPCs RI= 0.94 ± 0.02; n = 13; P = 0.04* Mann-
Whitney U test) (Figure 4.5E-G). This was accompanied by decrease in the 
AMPARs single-channel conductance in pre-myelinating OPCs (Control 
OPCs 35 ± 2.8; n = 10) pre-myelinating OPCs (21.61 ± 1.3 n = 5; P = 
0.01** Man-Whitney U test) (Figure 4.5H). These results are consistent 
with a reduction in CP-AMPARs in pre-myelinating OPCs. However this 
effect could also be attributed to a loss in the expression levels of mGluR5.  
To examine whether there were alterations in mGluR mediated plasticity 
during OPCs differentiation pre-myelinating cells were exposed to DHPG 
(100µM) and the AMPAR mediated current rectification was measured 
using whole cell I/V ramps in the presence of 100µM glutamate + 
cyclothiazide. Interestingly, the mGluR-mediated plasticity of AMPARs was 
absent in pre-myelinating OPCs (Control RI= 0.94 ± 0.02 DHPG RI= 1 ± 
0.06; P = 0.12 (Figure 4.5E). These results confirm that the expression 
levels of CP-AMPARs are downregulated as previously suggested from 
biochemical assays (Itoh et al., 2002). Importantly, we show that mGluR 
mediated AMPARs plasticity is developmentally regulated as it is absent in 
pre-myelinating cells.  
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Figure 4.5. mGluR induced change in CP-AMPARs is developmentally 
regulated in optic nerve OPCs. 
(A) Typical example of an optic nerve OPC (treated with PDGF and bFGF for 6 days 
in vitro) identified with the marker O4. (B) Averaged ramp I-V plots (+60mV to -
100mV) obtained from OPCs exposed to bath application of	   100µM glutamate.+ 
cyclothiazide. Control OPCs (black I-V) (n = 13), were compared with DHPG 
(100µM, 30 mins) treated cells (red I-V) (n = 13). DHPG treatment significantly 
reduced RI (current amplitude at +60mV vs -60mV) from a control value of RI = 0.7 
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± 0.04, to RI = 0.47 ± 0.02 (P  = 0.006**). (C) Immature OPC average AMPAR 
responses from outside-out patch exposed to fast application of 10mM glutamate 
(100ms, -60mV). Insets show plots of noise variance vs inward current. (D) Example 
of pre-myelinating OPC (identified with the marker O4) obtained by starving 
immature OPCs of growth factors and addition of thyroxine for 48hours. (E-G) 
Averaged ramp I-V plots (+60mV to -100mV) obtained from pre-myelinating OPCs 
exposed to bath application of	  100µM glutamate+ 50µM cyclothiazide. Control pre-
myelinating OPCs (black I-V) (n =  6), were compared with DHPG (100µM, 30 mins) 
treated cells (red I-V) (n =  6). mGluR activation did not alter the AMPAR RI (current 
amplitude at +60mV/ 60mV) from a control value of RI = 0.94 ± 0.02, to DHPG 
treated RI = 1 ± 0.06  (P = 0.12; unpaired t-test) (F) Average responses from 
outside-out patch exposed to fast application of 10μM glutamate (100ms, -60mV) in 
pre-myelinating OPCs. Inset shows plot of noise variance vs inward current (H) The 
single-channel conductance of AMPARs in OPCs decreased during development 
from 35pS ± 2.8 (n = 10) in OPCs, to 21.61 ± 1.349 (n = 5) in adult cells (P = 0.01**). 
Statistics used were unpaired t-test and Anova.  
 
4.3.6. Activation of P2Y receptors increases insertion of GluA2 
containing AMPARs in the surface of optic nerve OPCs 
 
The previous experiments have focused on mGluR meditated AMPAR 
plasticity in optic nerve OPCs. mGluRs in these cells are potentially 
activated by the release of glutamate from axons. However ATP is also 
thought to be released from optic nerve axons (Hamilton et al., 2010). To 
investigate whether application of ATP could also modify AMPAR 
properties in OPCs. Cells were exposed to 1mM ATP for 10minutes. 
Initially, we measured the effects of ATP on whole-cell AMPAR rectification 
index (+60/-60). In contrast with mGluR activation, ATP produced a 
	   102 
significant increase in rectification index compared with control cells 0.55 ± 
0.07 to ATP treated RI= 0.911 ± 0.1 (n = 6 and n = 8) (P = 0.005**). This 
change in is indicative of an increase in the proportion of calcium 
impermeable at the surface of OPCs following treatment with ATP, and 
contrasts with the increase in CP-AMPARs that follows DHPG treatment.  
The effects of ATP on AMPAR plasticity could inhibited with the P2 receptor 
antagonist PPADS (10µM) (PPADS+ATP RI= 0.522 ± 0.04 n = 5 P = 0.78 
compared with control). To investigate whether ATP mediated AMPA 
plasticity was mediated through the G-protein coupled receptor (GPCR) 
P2Y receptor, cells were treated with ATP and the cell permeable PLC 
inhibitor RHC-80267 (20µM). RHC-80267 blocked the effect of ATP on 
AMPA plasticity (RHC-80267 +ATP RI = 0.63 ± 0.03; n = 6; P = 0.7). These 
results strongly suggest that activation of P2Y receptor activation generates 
an increase in the proportion of calcium impermeable AMPARs in OPCs.  
ATP has previously been shown to increase the intracellular Ca2+ in NG2+ 
OPCs (Hamilton et al., 20101). To determine whether an increase in 
intracellular Ca2+ is involved in P2Y activated AMPAR plasticity, in OPCs, 
cells were treated with 20µM BAPTA-AM + ATP. In these conditions the 
effects of ATP were significantly reduced (RI BAPTA-AM + ATP = 0.55 ± 
0.05; n = 6; P = 0.45 compared to control; n = 6 P = 0.9) (Figure 4.6D) 
suggesting that an increase in intracellular Ca2+ is involved in the P2Y 
induced AMPAR plasticity.  
We next examined whether P2Y mediated plasticity is dependent on 
protein synthesis. OPCs were treated with C-hex (25µM) and 1mM ATP 
and AMPA rectification measured. In contrast with mGluR dependent 
change, ATP mediated AMPAR plasticity was not dependent on C-hex (C-
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hex + ATP RI = 0.82 ± 0.05; P = 0.019 compared to control RI; n=5). These 
results suggest that AMPAR plasticity mediated through mGluR and P2Y 
receptors involve different intracellular pathways.  
As described above, P2Y activation produces an increase in GluA2 
containing AMPAR. This would therefore be expected to produce a 
decrease in single-channel conductance of AMPARs in OPCs. The effects 
of ATP on AMPAR channel properties in OPCs were examined. Cells were 
treated with 1mM ATP for 10minutes at room temperature, and single 
channel properties were analyzed from control and ATP treated outside-out 
patches. ATP significantly decreased the AMPAR single-channel 
conductance from, control cells 35.65 ± 3pS n = 8 to ATP treated cells 
17.37 ± 2.4pS n = 7 (P = 0.002) (Figure 4.7C). This decrease in channel 
conductance is further evidence of an increase in calcium impermeable 
AMPARs. Interestingly the desensitization kinetics of AMPARs from ATP 
treated were significantly slower when compared with control AMPARs 
(control τdes = 4.8 ± 0.4ms, ATP τdes = 6.8 ± 0.6ms; P = 0.01), as might be 
expected for an increased incorporation of GluA2 containing AMPARs 
receptors (Oh et al., 2006) (Figure 4.6E).  
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Figure 4.6. ATP regulates AMPARs properties in optic nerve OPCs. 
(A-C) Whole cell I-V plots and averaged I-V plots obtained in response to 100µM 
glutamate (+60/-100) applied to cells bathed in either in control external solution or in 
external solution containing 1mM ATP for 10minutes at 250C. Activation of P2 receptor 
increased AMPAR rectification index from control cells 0.55 ± 0.07 to ATP treated cells 
R1= 0.911 ± 0.1; P = 0.005**; n = 6 and n = 8. (D) The increase in AMPAR RI response 
produced by ATP were reduced with the addition of either P2 antagonist PPADS, the 
phospholipase C inhibitor RHC 82067 and the calcium chelator BAPTA-AM (RI = 
PPADS+ATP = 0.52 ± 0.04 n = 5; P = 0.7 compared to control RI; RHC-82067 RI = 0.63 
± 0.03; P = 0.47 compared to control; n = 5; BAPTA-AM RI = 0.55 ± 0.05; n = 6; P = 0.9 
compared to control). Cyclohexamide did not effect ATP mediated AMPAR plasticity in 
OPCs (C-hex + ATP RI = 0.82 ± 0.05; P=0.019* compared to control RI; n=5). Kruskal-
Wallis rank sum test followed by pair wise Wilcoxon rank sum tests with Holm’s 
sequential Bonferroni correction 
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Figure 4.7. Purinergic receptor activation alters AMPAR channel properties 
in OPCs. 
(A-B) Average responses to fast application of 10mM glutamate (100ms, -60mV) to 
outside-out patches. Control current is the mean of 88 traces; ATP treated current is the 
mean of 40 traces. Insets show plots of noise variance vs. inward current. (C) The 
estimated mean channel conductance was significantly decreased with the application of 
1mM ATP, conductance of control cells 35.65 ± 3pS n = 8 reduced to 17.37 ± 2.4pS 
following ATP treatment (n = 7; P = 0.002**) (unpaired t-test). (D) The Po,peak of the 
AMPARs remained unaltered after treatment with ATP  (Control Po,peak 0.8 ± 0.07, ATP 
0.9 ± 0.06) (ns). (E) ATP increased AMPAR desensitization (control τdes = 4.8 ± 0.4ms, 
ATP τdes = 6.8 ± 0.6ms) (P = 0.005**) (unpaired t-test).  
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4.3.7. OPCs express TARPs 
 
Previous studies have identified TARPs as important proteins in controlling 
the properties of AMPARs involved in hippocampal plasticity (Rouach et al., 
2005; Tomita et al., 2005b). However was unknown whether TARPs are 
expressed in OPCs, and whether they are required for mGluR mediated 
AMPA receptor plasticity in these cells. To identify the possible TARPs 
expressed in optic nerve OPCs, the mRNA was extracted from the optic 
nerves of P7 rats and RT-PCR were carried out using primers for TARPs 
(γ-2, γ-3, γ-4, γ-5, γ-7 and γ-8) and the TARP related proteins γ-1 and γ-6. 
We detected γ-2, γ-3, γ-4, γ-5 and γ-6, (Figure 4.8 A).  
To further identify which TARPs are present in OPCs, cells were labeled 
with anti-γ-2/γ-8 (pan-TARP), anti-γ-5 and anti-γ-7 antibodies, however they 
did not label with γ-5 or γ-7 antibodies (Figure 4.8 B). It is possible that the 
mRNA detected for γ-4 and γ-5 is produced from GFAP positive astrocytes 
present in the optic nerve. It is also plausible that during differentiation of 
OPC into premeylinating cells and eventually into oligodendrocytes the 
expression levels of TARPs could alter. To address this OPCs were treated 
with thyroxine to induce differentiation into mature OPCs (identified with the 
antibody against the cell surface antigen O4) and into oligodendrocytes 
(identified with the an antibody against the cell surface antigen only 
expressed in oligodendrocytes O1). These cells were treated with anti-γ-5 
ant-γ-7 and anti-γ-2-/γ-8. Premyelinating OPCs labeled with O4 and γ-2/γ-8, 
and similar to immature OPCs did not label with anti-γ-5 or with anti-γ-7, 
however there were reduced expression levels for γ-2/γ-8 in 
oligodendrocytes (Figure 4.8 C-D).  
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Figure 4.8. Immature and differentiated optic OPCs express TARPs.  
(A) TARP cDNA expression pattern in rat optic nerve. γ-2 is highly expressed with a 
faint expression for γ-3 and the TARP related protein γ-6 n = 3. (B) Confocal image 
displaying typical example optic nerve OPC labeled with anti-γ2/γ8 (red) antibody 
and O4 (green). Cells labeled with the antibody against O4 and γ-2/γ-8 (C) Example 
of a premyelinating optic nerve OPCs labeled with anti-γ2/γ8 and O4. (D) Optic 
nerve oligodendrocytes labeled with marker O1+ showed reduced expression of 
TARP compared with pre-myelinating cells (n = 20 OPCs; n = 15 premyelinating 
OPCs; n = 21 oligodendrocytes) (Scale 25µm).  
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4.3.8. TARPs control AMPAR channel conductance in OPC  
The TARP γ-2 has been shown to increase AMPAR channel conductance 
in expression systems (Figure 2A chapter 3). The PDZ domain of γ-2 is 
critical for the interaction between TARPs and the synaptic protein PSD-95 
(Bats et al., 2007). Chen et al., 2000 demonstrated that in granule cells 
from stargazer mice it is possible to rescue surface AMPARs by 
transfecting cells with γ-2. In contrast, transfecting these cells with a mutant 
construct of γ-2, that lacked the ‘TTPV’ PDZ binding domain, failed to 
rescue the AMPARs responses.  
Is γ-2 required to control functional properties of surface AMPAR in OPCs? 
To address this, cells were transfected with either GFP control or with a 
mutant γ-2 construct (GFP γ-2Δ308) that is lacking in the ‘TTPV’ PDZ 
binding domain. The AMPAR channel properties in these cells were 
examined from glutamate evoked responses from excised patches. The 
AMPAR channel conductance was significantly reduced in γ-2Δ308 
transfected cells compared with control GFP transfected OPCs (control 
singe channel conductance = 39 ± 5pS to conductance of 21 ± 1pS for γ-
2Δ308 transfected cells; n=6 and n = 6; P = 0.007**. The AMPAR channel 
desensitization properties remained unchanged between GFP and the γ-2 
Δ308 transfected cells (control 5.2 ± 0.33ms, γ-2Δ308 5.1 ± 0.6ms). These 
results suggest that the -TTPV PDZ domain of γ-2 is critical for regulating 
the AMPAR in OPCs. It seems possible that the reduction in the single-
channel conductance could be attributed to altered trafficking and cell 
surface expression of CP-AMPARs in OPCs, to explore this I will be next 
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addressing the rectification properties in OPCs expressing TTPV mutant γ-
2.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Surface expression of functional CP-AMPARs in optic OPCs is 
dependent on the C-tail of γ-2. 
(A-C) OPCs were transfected with GFP-γ-2, GFP γ-2 308 ΔC308. Current variance 
traces from OPC transfected with GFP (mean of 90 traces) and GFP-γ2 ΔC308 
(mean of 52 traces) were obtained from outside-out patches of rapid application of 
10mM glutamate (100ms, -60mV). (D) The overexpression of γ-2 Δ308 produced a 
significant reduction in single-channel conductance to 21 ± 1pS (n = 6) (P=0.007** 
unpaired t-test). (E) γ-2Δ308 does not alter AMPA channel desensitization from 
control 5.2 ± 0.33ms to γ-2 γ-2Δ308 truncation 5.1 ± 0.6ms (ns unpaired t-test). 
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4.3.9. TARP γ-2 regulates mGluR plasticity  
As the deletion of the C-terminus of γ-2 in OPC produced a reduction in 
single-channel conductance of AMPARs is consistent with a loss of CP-
AMPARs, it was possible that when group I mGluRs are activated in OPCs, 
γ-2 maybe is responsible for the delivery of CP-AMPARs to the cell surface.  
To determine whether γ-2 was controlling the trafficking of CP-AMPARs in 
subunit specific manner I transfected OPCs with either full-length γ-2 in a 
GFP vector or with γ-2ΔC308 mutant also in a GFP vector. The expression 
of the γ-2Δ308 mutant significantly increased the AMPAR rectification index 
compared with that of OPCs transfected with full-length γ-2 (γ-2 wild-type 
RI= 0.5 ± 0.03, γ-2Δ308 RI= 1.1 ± 0.05; P = 0.001) (Figure 4.12). These 
results suggest that γ-2 can participate in regulating the trafficking of CP-
AMPARs in OPCs.  
Such a deficiency in the delivery of CP-AMPAR to the membrane in OPCs 
expressing γ−2Δ308 could affect mGluR AMPAR plasticity. To investigate 
this possibility, γ-2Δ308 transfected cells were stimulated with DHPG. Cells 
transfected with γ-2Δ308 did not show a decrease in AMPAR rectification in 
response to mGluR activation (γ-2Δ308 RI = 1.1±0.05 γ-2Δ308+DHPG RI= 
1.0±0.08), providing evidence that full-length γ-2 is required for mGluR 
dependent AMPAR plasticity in OPCs.  
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Figure 4.10. Changes in CP-AMPAR surface expression involves the C-
terminus of γ−2.  
(A-B) OPCs were transfected GFP-γ2 or GFP-γ2 (ΔC308). Whole-cell ramp I-V plots	  
(+60/-100) were obtained from γ-2 overexpressing and expression of γ2 ΔC308 mutant 
cells in response to 100µM glutamate. The expression of the C-terminal mutant of γ2 
significantly increased the AMPAR RI = 0.5 ± 0.03 in γ2 overexpressed cells, to RI γ2 
ΔC308 = 1.1±0.05 (unpaired t-test P<0.001**). (C) Treatment with 100µM DHPG for 30 
minutes no longer triggered an increase in rectification in cells transfected with the C-tail 
truncated mutation. In OPCs transfected with γ-2 ΔC308 RI=1.1±0.05 in control and 
1.0±0.04 following DHPG treatment) (not significant; unpaired t-test). 
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4.3.10. Neuronal calcium sensor proteins co-localise with 
TARPs in OPCs 
Calcium sensing proteins have been found to control mGluR plasticity and 
facilitate synaptic transmission in neurons. The neuronal calcium sensor protein 1 
(NCS-1) is a homolog of the Drosophila protein frequenin, and has recently been 
shown to control mGluR-LTD. A study by Jo et al., 2008 demonstrated that 
mGluR5 activation triggers an increase in intracellular Ca2+, in neurons activating 
NCS-1, which subsequently binds directly to PICK-1 and forms a complex with 
AMPA receptors, triggering internalisation (Jo et al., 2008).  
As γ-2 is important for mGluR mediated AMPA plasticity in OPCs it was possible 
that an increase in intracellular Ca2+ could also trigger calcium-sensing proteins, 
which could regulate mGluR plasticity OPCs. To explore this possibility whether 
OPCs expressed the neuronal calcium sensor NCS, we initially treated cells with 
a specific antibody against NCS-1. Surprisingly we found high levels of the NCS-
1 a protein in OPCs previously thought to be localized only in neurons. 
Furthermore, there was a high degree of a co-localisation of NCS-1 and γ-2 
(Figure 4.11). This finding demonstrates that in many respects the mechanisms 
that control mGluR plasticity in neurons are similar in OPCs.  
 
 
 
 
 
Figure 4.11. Neuronal calcium sensing (NCS-1) protein 1 is present in OPCs 
and colocalises with γ-2. 
(A-B) Optic nerve OPCs stained with anti-NCS-1 and anti-γ2/γ8. There was an 80% 
colocalisation between NCS-1 and TARPs  (n=10).  
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4.4. Discussion  
The results described in this chapter suggest that the properties of AMPARs in 
OPCs can be regulated by activation of group 1 metabotropic receptors 
(mGluR5) and ionotropic purinergic receptors (P2Y). The experiments 
demonstrated that stimulation of group I mGluRs produce an increase in the 
relative proportion of CP-AMPARs in the surface membrane of OPCs, while in 
contrast activation of P2Y receptors decrease relative proportion of CP-AMPARs. 
Various intracellular pathways have been implicated in the mGluRs mediated 
AMPAR plasticity previously described in neurons (Kelly et al., 2009). In the 
present study we found certain key intracellular pathways may also be important 
in the regulation of AMPAR plasticity in OPCS. Interestingly, we also demonstrate 
that the TARP γ-2 plays a key role in this plasticity in glia.  
4.4.1. Possible physiological implications of mGluR mediated 
AMPAR plasticity in OPCs 
The present experiments provide evidence that mGluR activation can mediate a 
form of AMPAR plasticity that results in an increased insertion of CP-AMPARs in 
the surface of OPCs. Is this likely to be of physiological or pathological relevance 
in the CNS? It has been demonstrated that release of glutamate from axons and 
also from certain glial cells (astrocytes) is a major source of the transmitter in the 
white matter (Kukley et al., 2007). mGluR activation and an associated increase 
in calcium permeable AMPARs could therefore occur in OPCs in situ and 
potentially influence their normal proliferation and differentiation and may affect 
OPC survival following white matter damage.  
Furthermore, recent evidence suggests that evoked release of transmitter 
(glutamate) from nerve terminals in the hippocampus onto OPCs causes a switch 
from calcium impermeable CI- to CP-AMPARs in these cells (Ge et al., 2006).  
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Although the mechanism underlying this change was not previously explored in 
detail, our results would strongly suggest that it is likely to involve activation of 
mGluRs. It is of particular interest the mGluR activation alters the proportion of 
CP-AMPARs in neurons, but invariably results in a loss (rather than an increase) 
in CP-AMPARs  (Mameli et al., 2007;Kelly et al., 2009). Why does mGluR 
activation differ in its effect on AMPAR plasticity in OPCs and interneurons? 
Interneurons in the cerebellum and VTA express multiple TARPs including γ-2 
and γ-7; they also express the postsynaptic density protein PSD-95. However, 
OPCs appear to express only γ-2 and SAP-97 (Kato et al., 2007). Therefore, a 
potential difference in the mGluR plasticity between neurons and glia could be 
attributed to γ-7.  The TARP γ-7 has been shown to have a unique C-terminal 
domain making it is possible that it is interacting with a variety of different 
trafficking proteins (Deng et al., 2006). It is also possible that activation of 
mGluR1 in neurons can phosphorylate the C-terminus of γ-7 resulting in an 
increased insertion of GluA2 containing AMPARs to the surface of neurons. In 
contrast, in OPCs stargazin may preferentially increase the expression of 
GluA4/GluA3 containing AMPARs to the surface. It would therefore be of interest 
to transfect OPCs with γ-7 and observe whether the mGluR dependent AMPAR 
plasticity produced is similar to the plasticity seen in neurons.  
During development immature OPCs are expressed throughout the CNS and are 
highly proliferative prior to forming myelinating oligodendrocytes (Bogler et al., 
1990; Raff et al., 1988). Factors that regulate their migration, and differentiation 
of immature OPCs into oligodendrocytes, have been the focus of numerous 
studies, which have identified activation of AMPARs as a factor that can regulate 
the differentiation of OPCs into myelinating cells (Yuan et al., 1998).  Thus, 
treating cerebellar slices with AMPAR agonists decreases both the proliferation 
and the number of OPCs (Yuan et al). However, the signaling mechanism that 
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controls the anti-proliferative properties of glutamate has not been explored in 
any detail. It is possible that the activation of mGluRs in OPCs may be a 
contributing factor in the ability of glutamate to halt OPC proliferation.  
It is also of note that the effect of mGluR activation on the proliferative properties 
of OPC can be important following white matter damage, after brain trauma, 
where there is evidence that OPCs are attempting to remyelinate neurons 
(Carroll et al., 1998). The increased release of glutamate due to tissue damage 
during white matter damage can ‘overactivate’ mGluRs in OPCs, potentially 
reducing the ability of OPCs to re-populate the demeylinating plaque (Rothman 
and Olney, 1986).  
OPCs are derived from early progenitor cell (O2A progenitors). O2A progenitors 
have high expression levels of mGluR1 and mGluR5; these cells also express 
mixtures of calcium impermeable and CP-AMPARs. Activation of mGluR1/5 has 
been shown to protect O2A progenitors from cell damage caused by exposure to 
high levels of kainate and staurosporin (Deng et al., 2004; Luyt et al., 2006). This 
neuroprotective effect of mGluR1/5 could be due to activation of serine/threonine 
kinase Akt, which is important for neuronal cell survival (Datta et al., 1999). 
However, there is evidence that as O2A progenitors differentiate into OPCs, there 
is a decrease in the expression of mGluR1 with only low levels of mGluR5 
remaining (Deng et al., 2004). An increased calcium influx through CP-AMPARs 
has been linked to increased cell death of OPCs (Alberdi et al., 2002). The 
reduced expression of mGluR1 during differentiation of O2A progenitors can lead 
to an increased susceptibility of immature OPCs to cell death during ischemia, as 
the activation of remaining mGluR5 could still result in an increase in CP-
AMPARs, without the associated increased activation of the protective Akt 
pathway provided by mGluR1.  
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Figure 4.4.1.2. Hypothetical model of mechanisms contributing to OPC cell 
death. 
(A) O2A progenitors express high levels of mGluR1, mGluR5 and CI and CP-
AMPARs. The activation of mGluR1/5 in O2A progenitors may have a 
neuroprotective effect as it initiates the Akt pathway. (B) During the differentiation 
of O2A progenitors into OPCs there is a loss of mGluR1 and reduced expression 
levels of mGluR5; however, these cells still express CP-AMPARs. (C) Immature 
OPCs undergo mGluR mediated AMPAR plasticity after the release of glutamate 
from axons and astrocytes, resulting in an increased proportion of CP-AMPARs at 
the surface. (D) Excessive release of glutamate during hypoxia could activate the 
remaining mGluR5 that promote the insertion of CP-AMPARs in OPCs, thus 
leading to cell death.  
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4.4.2. ATP produces a novel plasticity in OPCs 
The present experiments also demonstrate that the neurotransmitter ATP 
produced a form of AMPAR plasticity that results in replacement of CP-AMPARs 
by CI-AMPARs in OPCs.  ATP is known to be released from axons and 
astrocytes in the brain (including optic nerve) thus resulting in increased 
intracellular levels of [Ca2+]i in OPCs (Hamilton et al., 2010; Ishibashi et al., 
2006).  
ATP is a relatively unusual transmitter as it is rapidly degraded into adenosine, 
which acts on another group of G-protein, coupled receptors A1, A2 and A3 
(adenosine receptors). Adenosine has been shown to activate OPC 
differentiation in myelinating oligodendrocytes (Stevens et al., 2002). In the 
present study we found that mature premyelinating OPCs have reduced 
expression of CP-AMPARs. It is possible that in vivo ATP can prime OPC for 
differentiation into myelinating cells by reducing expression of CP-AMPARs and 
promoting differentiation via activation of the adenosine pathway. However, in a 
recent study it was proposed that pre-myelinating OPCs receive fewer 
glutamatergic inputs from neurons, which may argue against this.  Nevertheless, 
it is possible that the levels of ATP released from astrocytes and axons may 
remain constant during development, which could be a potential mechanism for 
controlling OPC differentiation and for the reduced expression of CI-AMPARs 
during development (Kukley et al., 2010).  
What are the reasons for the reduced expression of CP-AMPARs during 
differentiation of OPCs into oligodendrocytes? Pende et al demonstrated that 
increased calcium influx through AMPARs increases the expression of NGFI-A 
and c-fos, which are markers for elevated protein expression (Pende et al., 
1994). It is possible that OPCs require Ca2+ influx through CP-AMPARs early in 
development to allow them to migrate to nerve axons and differentiate into 
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myelinating cells (Gudz et al., 2006). However, once OPCs have differentiated, 
nerve terminals will require oligodendrocytes to become stationary. It may thus 
be beneficial for the expression of CP-AMPARs to be reduced in myelinating 
oligodendrocytes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1.3. Hypothetical model of ATP regulation of the maturation of 
OPCs. 
(A) ATP released from axons and astrocytes may activate P2Y receptors expressed in 
OPCs, leading to a reduced proportion of CP-AMPARs (B) ATP may then be rapidly 
degraded into adenosine, resulting in differentiation of OPCs into oligodendrocytes.  
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4.4.3. Key intracellular kinases control glial AMPAR plasticity in 
OPCs 
mGluR1 mediated AMPAR plasticity in VTA neurons and cerebellar interneurons 
are thought to be regulated by the PI3K-Akt-mTOR pathway. We found that 
mGluR5 dependent AMPAR plasticity in OPCs is also regulated by PI3-kinase 
and protein synthesis. However, in contrast with the situation in neurons, in OPCs 
activation of mGluRs increases the proportion of CP-AMPARs. It seems possible 
that activation of mGluR5 in OPCs could result in the activation of several as yet 
unidentified auxiliary proteins that preferentially traffic CP-AMPARs. The 
activation of CP-AMPARs in O2A progenitors has been shown to increase levels 
of c-jun and activate early immediate genes (Pende et al., 1994). In the current 
study we identify that c-jun N-terminal kinases can control mGluR plasticity in 
OPCs. It is likely that activation of mGluRs, together with activation of CP-
AMPARs, acts to increase mRNA expression, promoting increased expression 
levels of CP-AMPARs in the surface of OPCs.  
Activation of mGluRs in neurons triggers the activation of the protein Homer, 
increasing intracellular calcium. This rise in intracellular calcium is believed to 
activate PICK-1, thereby initiating internalization of AMPARs. It was previously 
unknown whether PICK-1 regulates AMPARs in glial cells. We find compelling 
evidence that PICK-1 is important in regulating internalization of GluA2 containing 
AMPARs from the surface of OPCs.  
4.4.4. TARPs play a unique role in OPCs 
Previous studies have shown that AMPAR channel conductance in Bergmann 
glial cells is controlled by the TARP γ-5. The TARPs that regulated AMPARs in 
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OPCs and oligodendrocytes were unknown. In the present study we find that 
stargazin is expressed in OPCs and is important in AMPAR regulation.   
Firstly, we identified that γ-2 influences the single-channel conductance of 
AMPARs in OPCs. Importantly we find that the –TTPV PDZ binding domain of γ-2 
is critical for its ability to control the trafficking of CP-AMPARs in the surface of 
OPCs, as previously seen in cerebellar granule cells (Chen et al., 2000). 
Secondly, we found that γ-2 regulates mGluR mediated AMPAR plasticity in 
OPCs. Previous studies have shown that phosphorylation of serine residues in 
the C-terminus of γ-2 can regulate neuronal LTP and LTD (Tomita et al., 2005).  
Thus, a potential model for the role of γ-2 in OPC mGluR plasticity is that the 
increased influx of intracellular calcium can lead to the activation of protein 
kinases, which in turn phosphorylate the C-terminus of γ-2.  Increased 
phosphorylation of the C-terminus of γ-2 could enhance the ability of γ-2 to 
interact with PDZ binding proteins, resulting in increased delivery and 
stabilization of CP-AMPARs in the surface of OPCs. Previous work has also 
demonstrated that early in development the phosphorylation by PKA of Ser-482 
in GluA4 is necessary and sufficient for GluA4-containing AMPARs to be 
delivered to neuronal synapses (Correia et al., 2003). It is possible that in OPCs 
the activation of mGluR may also increase the phosphorylation of GluA4 resulting 
in increased association with γ-2, thereby leading to a preferential increase in 
stability of GluA4 containing AMPARs at the surface of OPCs.  
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Chapter 5. Cornichon proteins CNIH2/3 are expressed 
on the cell surface of oligodendrocyte precursor cells 
and regulate the properties of AMPARs 
 
5.1. Summary  
As described in chapter 4, TARPs have been demonstrated to control 
functional properties of AMPARs. Recently, a new family of AMPAR 
interacting proteins was identified. The cornichons, CNIH2 and CNIH3 are 
a family of transmembrane proteins that appear to act as AMPAR auxiliary 
proteins. In a previous study CNIH2/3 expression has been identified in 
neurons and glia of the cerebellum and in hippocampal neurons (Lien et 
al., 2007; Schwenk et al., 2009). CNIH2 and 3 show some apparent 
similarities to TARPs in their ability to control AMPAR properties in 
expression systems, regulating the trafficking and the kinetic properties of 
AMPARs. However, in a very recent study it has been proposed that 
cornichons are not able to modulate the properties of cell surface AMPARs 
in neurons, as ‘cornichoned’ receptors fail to reach the cell surface in 
neurons (Shi et al., 2010). Here, we have Immunofluorescence data 
demonstrating that cornichons are expressed in the cell surface of 
cerebellar glial cells and OPCs.  
Furthermore, electrophysiological methods were used to examine whether 
cornichons can modulate the properties of cell surface AMPARs in OPCs 
in which CNIH3 has been overexpressed. In these conditions CNIH3 
significantly slowed AMPAR desensitisation, without changing AMPAR 
rectification properties. In addition we examined whether the 
overexpression of CNIH3 altered the AMPAR response to kainate.  
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5.2. Introduction  
The identification of TARPs has led to a search for other potential 
transmembrane AMPAR interacting proteins in the CNS. Schwenk et al., 
2009 identified the cornichon-like proteins CNIH2 and CNIH3 as AMPAR 
interacting proteins by proteomic C-terminus analysis of native GluA2 
complexes (Schwenk et al., 2009). Cornichons are a family of 4 
transmembrane proteins (CNIH1, CNIH2, CNIH3 and CNIH4). The 
expression of tagged CNIHs in HeLa cells has previously revealed a partial 
overlap with the Trans Golgi network (TGN) marker GM130. In addition to 
their presence in the TGN, CNIHs also partially colocalize with the 
endogenous COPII vesicle coat complexes that are present in the 
endoplasmic reticulum (ER) exit sites (Castillon et al., 2009; Castro et al., 
2007). These results are suggestive of a role for CNIHs in chaperoning 
proteins through the ER to the TGN. 
Schwenk et al., 2009 used an antibody raised against CNIH2 and CNIH3 
to label cells in the hippocampus and in the cerebellum. Their study 
revealed expression of CNIH2/3 in hippocampal pyramidal neurons, 
cerebellar Purkinje neurons and Bergmann glia. Furthermore, 
examinations using post-embedding electron-microscopy (EM) with the 
CNIH2/3 antibody detected CNIH2/3 in both postsynaptic and 
extrasynaptic sites in hippocampal cells. Biochemical experiments 
suggested that CNIH2 and CNIH3 interacted with native AMPARs and 
significantly increased the cell surface expression of GluA1 and GluA2. 
Finally, Schwenk and colleagues (2009) demonstrated that co-expression 
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of CNIH2 or CNIH3 with AMPAR in expression systems significantly 
slowed AMPAR deactivation and desensitisation kinetics. 
By contrast, a recent study has provided evidence that CNIH2 functions as 
an intracellular trafficking molecule in the neurons, rather than regulating 
neuronal cell surface AMPARs (Shi et al., 2010). The study addressed 
firstly whether CNIH2 and 3 influenced AMPAR properties in HEK293T 
cells. They found that, like TARPs, CNIH2 increased the conductance of 
GluA1 containing AMPARs. However when CNIH2 was overexpressed in 
stargazer granule cells or in hippocampal neurons, AMPAR properties 
were not affected in these cell types. To compare the expression of TARPs 
and CNIH2, Shi et al., 2010 transfected hippocampal neurons with FLAG 
tagged CNIH2 and showed that it was localised in the TGN and was 
absent from the cell surface. This study confirmed these findings using 
biochemical assays. Shi et al., 2010 concluded that CNIH2 and CNIH3 do 
not behave as TARPs and that ‘cornichoned’ AMPARs never reach the 
plasma membrane in neurons.  
Work in chapter 3 of this thesis revealed that the TARP γ-5 regulates CP-
AMPARs in cerebellar Bergmann glia (Soto et al., 2009). γ-5 was 
previously not considered to be a TARP as it failed to rescue the AMPAR 
expression in stargazer cerebellar granule cells (Tomita et al., 2003). In a 
similar manner CNIH2 when overexpressed in granule cells cannot modify 
the properties of cell surface. We were therefore interested in whether 
CNIH2 and CNIH3 could regulate the properties of AMPARs in glia. In this 
study we show, using immunofluorescence and electrophysiological 
techniques, that like TARPs, CNIHs can modify AMPAR properties in glia.  
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5.3. Results  
5.3.1. CNIH2/3 is expressed on the cell surface of cerebellar 
astrocytes  
To determine whether there are differences in the levels of expression of 
CNIH2/3 between neurons and astrocytes in the cerebellum, the 
expression pattern of CNIH2/3 was studied in cerebellar neuronal-astrocytic 
co-cultures (P7 rats DIV7). Initially, to confirm the presence of astrocytes in 
these co-cultures, cells were permeabilized with 0.1% triton and labelled 
with anti-rabbit GFAP. The cerebellar cultures were composed of GFAP 
staining astrocytes, together with neurones (probably granule cells and 
interneurons). Permeabilized cultures were then labelled with a CNIH2/3 
antibody (raised in rabbit against the entire sequence of the CNIH2 and 
CNIH3 proteins) and with anti-MAP2 antibody. CNIH2/3 is clearly 
expressed in neurons as well as in cells with astrocytic morphology (Figure 
5.1).  
The work of Shi et al., 2010 has proposed that CNIH2 is absent from the 
cell surface of neurons. To address the possibility that CNIH2/3 maybe 
present in the cell membrane of glial cells, non-permeabilized cerebellar 
neuronal-astrocytes were labelled with CNIH2/3. In contrast with CNIH 
labelling under permeabilized conditions, CNIH3 appeared to be only 
expressed in the surface of cells that display astrocytic morphology (Figure 
5.2). 
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Figure 5.1. CNIH2/3 is detected in permeabilized cerebellar glia and neurons.  
(A) Cerebellar glial cells grown for 7 days in the presence of 10% FCS were 
stained with GFAP. (B-D) Mixed neuron-astrocyte cultures were fixed with 4% 
PFA, permeabilized with 0.1% triton and stained with rabbit anti-CNIH2/3 (red) and 
anti-MAP2 (green). CNIH2/3 is localised in cells showing astrocyte morphology, 
and in MAP2 positive neurons. (Scale bar 30 µm).  
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Figure 5.2. CNIH2/3 is present in the cell surface of cerebellar glia. 
(A-B) Cerebellar neuron-glia cultures were fixed with 4% PFA and stained with 
anti-CNIH2/3 under non-permeabilized conditions. CNIH2/3 is highly expressed at 
the surface of cell glia cells (black arrow) and is expressed at lower levels in the 
surface of neuronal cells (white arrows)(Scale bars 25 µm).  
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5.3.2. CNIH2/3 is expressed in oligodendrocyte precursor cells  
We next considered whether CNIH2/3 is expressed in other glial cells that 
are known to express AMPARs. Oligodendrocyte precursor cells (OPCs) 
are a class of glial cells that have been previously demonstrated to 
express a mixture of AMPAR subunits, as described in chapter 4. 
Investigating which proteins can regulate AMPAR properties in OPCs is of 
particular importance as an increase influx of Ca2+ through OPC CP-
AMPARs has been linked to apoptosis of OPCs and white matter damage 
during hypoxia (Deng et al., 2003). 
To address whether CNIH2/3 is also expressed in optic nerve OPCs, we 
initially permeabilized OPCs and labelled them with anti-CNIH2/3 and with 
the antibody O4 (a marker for OPCs). In common with cerebellar 
astrocytes, OPCs express CNIH2/3 in their cell body and along the 
processes (Figure 5.3B). Furthermore under non-permeabilized conditions 
we found high levels of CNIH2/3 expression at the cell surface. 
It seems possible that CNIH2/3 expression may alter during the maturation 
of OPCs into highly differentiated pre-oligodendrocytes (as described in 
chapter 4). We found that the expression levels on CNIH2/3 were on 
average lower in adult pre-myelinating OPCs (Figure 5.3D). We also 
examined the expression pattern of CNIH2/3 in astrocytes from the optic 
nerve and found that under non-permeabilized conditions cornichons were 
also expressed. Interestingly, the expression of CNIH2/3 was not apparent 
in all astrocytes examined suggesting differences in the expression levels 
during differentiation (Figure 5.3A-B). These results are suggestive that 
CNIH2/3 is present in the cell surface of many glial cell types, indicating a 
potential role in the regulation of cell surface AMPARs.  
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Figure 5.3. CNIH2/3 is expressed at the cell surface of optic nerve glia. 
(A) Optic nerve astrocytes kept for 7-days in vitro were permeabilized or non-
permeabilized and labelled with CNIH2/3 antibody (scale bar 25µm). (B) Optic 
nerve OPCs under non-permeabilized conditions were stained with anti-O4 and 
anti-CNIH2/3.  CNIH2/3 is expressed at a high level in O4 positive cells (C) OPCs 
permeabilized with 0.5% triton and stained with anti-CNIH2/3 and O4 display a 
punctuate expression of CNIH2/3 in cell processes and cell soma (scale bar 
10µm)  (D) Mature pre-oligodendrocyte cells treated with thyroxine for 48 hours 
express low levels of CNIH2/3 compared to OPC (scale bar 25µm). 
 
5.3.3. CNIH3 overexpression alters OPCs cell surface AMPAR 
kinetics  
Next we wanted to examine whether cornichons could regulate the cell 
surface AMPARs on OPCs. In chapter 4, we demonstrated that the 
properties of cell surface AMPARs in OPCs match closely with that of 
TARPed AMPAR. It is therefore likely that the properties of OPC AMPARs 
are influenced by γ-2 rather the by cornichons. We therefore examined 
whether overexpression of cornichons could modify the rectification, 
conductance, and kinetics of AMPARs by co-overexpressing with GFP and 
cornichon cDNA. In this study I transfected OPCs with CNIH3 as it has a 
more widespread distribution in the CNS compared to CNIH2, which is 
highly localized to the hippocampus (Lein et al., 2007). 
Initially, we examined the properties of AMPARs from control OPC using 
outside-out patches exposed to 10mM glutamate, and found OPC AMPARs 
in control conditions to be composed of a mixture of both calcium 
permeable and calcium impermeable AMPARs (RI +60/-80 = 0.30 ± 0.02 n 
= 3) (Figure 5.4). We then examined the properties of OPC AMPARs when 
overexpressed with CNIH3, and found no alterations in the rectification 
index (RI = 0.34 ± 0.04 n=3 P = 0.29). These results indicate that over-
expression of CNIH3 did not alter the fraction of CP-AMPAR subunits. We 
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then examined whether CNIH3 could modify AMPAR channel conductance 
and kinetic properties of CNIH3 transfected OPCs. There were no 
alterations in the single-channel conductance of CNIH3 transfected OPCs 
(OPC 38 ± 3.8pS n = 7; +CNIH3 28.4 ± 3.8pS n = 6) (P = 0.09) (Figure 
5.5B). However the effect on desensitization kinetics of CNIH3 over-
expression was clear (τdes control = 5.31 ± 0.54ms n = 10 to CNIH3 τdes = 
9.87 ± 1.39ms n = 11) (P = 0.007**) (Figure 5.5C-F). 
This data suggests that CNIH3 is able to reach the cell surface in certain 
glial cells and modulate the properties of AMPARs, however it is less clear 
if CNIH2 or 3 modulates receptor function in non-transfected cells.  
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Figure 5.4. CNIH3 overexpression does not alter AMPAR rectification in 
OPCs. 
(A, B) AMPAR currents induced by application of 10mM glutamate to outside-out 
patches from control and CNIH3 transfected. (C) Inwardly rectifying I-V plots from 
AMPARs in responses to fast application of glutamate (10mM, 100ms) to outside-
out patches excised from OPCs. Currents were examined between -80 and 
+60mV (n=3 control; n = 3 CNIH3 overexpressed) (100µM spermine present in the 
intracellular solution). (D) Overexpression of CNIH3 did not modify the rectification 
of responses (control RI= 0.34 ± 0.02, and 0.3 ± 0.06 following CNIH transfection; 
n = 3, n = 3, P = 0.29 unpaired t-test), indicating the presence of GluA2 containing 
and GluA2 lacking AMPARs in both conditions.  
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Figure 5.5.  CNIH3 decreases AMPA channel desensitization in optic nerve 
OPC glia.  
(A) Glutamate evoked responses recorded from optic nerve OPC DIV 7 from 
control (n = 11) and from OPCs transfected with CNIH3 (n = 10). Mean of 45 
traces from control and mean 94 from CNIH3 transfected cells. Traces obtained 
from outside-out patches by rapid application of 10mM glutamate (100ms, 
+60mV). (B-D) Current variance plots from control and CNIH3 transfected OPCs. 
The estimated single-channel conductance was not significantly modified by 
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CNIH3 (control cells 35.3 ± 3.7pS CNIH3 transfected 29.06 ± 2.3pS (P = 0.09). (E-
I) Overexpression of CNIH3 significantly decreased AMPAR channel 
desensitization from control τW 5.31 ± 0.54ms to 9.87 ± 1.39ms in CNIH3 
transfected cells (P = 0.007**) and increased the AMPAR percentage steady state 
current from control 0.56 ± 0.02 to 2.98 ± 0.07 for CNIH3 transfected cells (P = 
0.031**).  
5.3.4. CNIH3 increases kainate induced AMPAR responses from 
OPCs  
In order to further evaluate the effects of CNIH3 on OPC AMPARs, we 
used a previously established assay to investigate the effects of TARPs 
on AMPAR pharmacology. The assay measures the different currents 
produced by the partial agonist kainate compared with glutamate (IKA/IGlu).  
This method has been used by Shi et al., 2009 to show that when TARPs 
are co-expressed with AMPARs the relative size of the AMPAR response 
is increased when activated with 1mM kainate, compared to 1mM 
glutamate (IKA/IGlu). It would therefore be interesting to understand if 
CNIH3 acts as a TARP and modifies the kainate induced AMPARs current 
when CNIH3 is overexpressed in OPCs.   
Initially we examined the IKA/IGlu ratio for untransfected OPC AMPARs by 
measuring activation with 1mM kainate and 1mM glutamate from outside-
out patches in the presence of 100µM cyclothiazide (to prevent AMPAR 
desentisation). Previous studies have shown that in expression systems 
the IKA/IGlu ratio for GluA1 alone was 0.02 and significantly increased to 
0.49 when co-expressed with γ-2 (Shi et al., 2009). Furthermore, a very 
recent study has shown that the IKA/IGlu ratio for GluA1 when co-expressed 
with CNIH2 is on average increased from 0.02 in control to 0.1 with 
CNIH2 (Shi et al., 2010). We found that the IKA/IGlu ratio for control OPCs 
were similar to the published IKA/IGlu ratio for GluA1+γ2 suggesting that the 
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majority of cell surface AMPAR present on OPCs are already associated 
with γ-2 (Control OPC IKA/IGlu ratio = 0.415 ± 0.04 n = 7) (Figure 5.6A). 
However to examine whether we could provide further evidence that an 
overexpression of CNIH3 can modify the properties of cell surface 
AMPARs on OPCs, we measured the IKA/IGlu ratio for OPCs transfected 
with CNIH3, and found that in CNIH3 transfected OPCs cells the AMPAR 
IKA/IGlu ratio significantly increased to 0.786 ± 0.1 n = 4 compared to 
control values of 0.414 ± 0.04) (P = 0.023) (Figure 5.6B). This increase in 
IKA/IGlu ratio for CNIH3 transfected OPCs was unexpected, as previous 
studies in expression systems have shown that GluA1+CNIH3 IKA/IGlu ratio 
to be 0.1. The fact that IKA/IGlu ratio is higher than would be expected might 
indicate co-operation between cornichons and TARPs, suggesting that the 
two auxiliary proteins can bind to the same receptor. To investigate this 
we have carried out preliminary studies in TSA201 cells transfected with 
GluA1+γ-2+CNIH3, and found that the IKA/IGlu ratio may be increased to 
0.592 (n = 2) compared to GluA1+γ-2 alone. This suggests that when 
AMPARs are associated with a mixture of TARPs and cornichons, there is 
an increase in the AMPAR response to kainate.  
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Figure 5.6. CNIH3 overexpression enhances kainate induced AMPAR 
currents in OPC.  
(A-B) Typical example of Kainate- (KA, 1 mM) and glutamate- (Glu, 1 mM) 
induced currents produced using outside-out patches from control OPC and OPC 
transfected with CNIH3. (C) CNIH3 significantly enhanced the IKA/IGlu ratio 
compared to control IKA/IGlu= 0.415 ± 0.04 n = 7 to IKA/IGlu CNIH3 = 0.786 ± 0.1 n=4 
(P = 0.023*).   
5.4. Discussion 
The aims of this study were to determine whether CNIH2/3 could modify 
the properties of AMPARs in glia. We have shown that CNIH2/3 are 
expressed in cell surface of glial cells from the cerebellum and optic nerve. 
Furthermore by overexpressing CNIH3 in OPCs we find that in contrast 
with the situation in neuron, CNIH3 can modulate the properties of cell 
surface AMPARs. This study therefore provides evidence that CNIH3 may 
	   136 
be capable of controlling the functional properties of cell surface AMPARs 
in a cell-type specific manner.  
Previously we have shown that AMPARs in glia are regulated by TARPs 
(Soto et al., 2009). In particular γ-5 regulates communication between 
neurons and Bergmann glia (Chapter 3 Figure 4.4). From the experiments 
described in the present chapter, it appears that cornichons are also 
expressed on the cell surface of glia and are capable of modifying AMPAR 
properties when overexpressed. An important question is whether AMPARs 
bind to both cornichons and TARPs in glial cells. To address this, further 
work will be needed, as our understanding of the stoichiometry of AMPARs, 
CNIHs and TARPs in glial cells remains unknown.  
The dramatic change in the kinetic properties of AMPARs when CNIH3 is 
overexpressed in OPCs suggests that either cornichons compete with other 
auxiliary proteins and displace them or alternatively that CNIH3 form a 
complex with other auxiliary proteins and AMPARs. Interestingly 
overexpression of CNIH3 did not modify the rectification properties of 
AMPARs suggesting that it does not selectively modify the trafficking of CP-
AMPARs. Consistent with this, we did not observe a change in the single-
channel conductance in CNIH3 transfected cells. 
It has been suggested in a recent study that CNIH2 is not present at the 
cell surface of granule cells and is localized mainly in the Golgi (Shi et al., 
2010). This raises the question as to why overexpression of cornichons can 
modify the cell surface properties of AMPARs in glial cells and not in 
neurons. The lack of change in the properties in CNIH2 transfected 
neurons could be due to the following: (i) there could be a more stringent 
secretory pathway in neurons, which could be lacking glia. This would allow 
the trafficking of ‘cornichoned’ AMPARs to the cell surface of glia and in 
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expression systems, (ii) CNIH3 could only modify the properties of specific 
AMPAR subunits in vivo. OPCs express a mixture of GluA2, 3 and 4 
whereas both cerebellar granule cells and hippocampal neurons express 
short form GluA2/4 heteromers, (iii) neurons express a wide variety of 
synaptic proteins, including PSD-95, which are important for regulating 
synaptic plasticity and have roles in stabilizing AMPARs at the cell surface. 
However it is possible that CNIH3 can traffic to the cell surface of OPCs 
due to the expression of a unique trafficking protein that may be absent in 
neurons resulting in AMPAR bound to CNIH2 or CHIN3 remaining in the 
TGN.  
Shi et al., 2009 demonstrated that the expression of a covalently linked 
TARP-AMPAR complex significantly increase AMPAR responses to 
kainate. When overexpressing the TARP γ-8 in hippocampal neurons the 
IKA/IGlu was significantly increased. In this study I have shown that an 
increase in CNIH3 expression in OPCs also produces an increase in the 
AMPAR response to kainate, thus suggesting that the cell surface 
receptors are coupled to CNIH3, which has the ability to modify the 
functional properties.  
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6. General discussion 
 
The experiments described in this thesis I have identified novel proteins 
and intracellular pathways potentially important for controlling glial 
AMPARs.  
In Chapter 3 we identified that the novel TARP γ-5 regulates the properties 
of AMPARs in BGC and is associated with the protein SAP-97. 
Interestingly, in contrast with other established TARPs, γ-5 suppresses the 
cell surface trafficking of AMPARs, which is regulated through the 
lysosomal pathway. We also found that, unlike other TARPs, γ-5 appears 
to be highly localised to glial cells, being present in cerebellar BGC and in 
glia of the olfactory bulb and spinal cord. It would clearly now be of interest 
to determine whether γ-5 is involved in regulation of AMPARs in spinal 
cord and olfactory bulb glial cells. There is evidence for the presence of 
ensheathing glial cells (OEC) in the olfactory bulb. Like Bergmann glia in 
the cerebellum OECs also seem to be important for axon guidance. 
Indeed, OECs have been linked to increased neuronal cell survival (Au et 
al., 2007). It would be of interest to investigate whether OECs express CP-
AMPARs, and whether γ-5 regulates the interaction between OECs and 
olfactory neurons. Methods similar to those used by Iino et al. (2003) in 
their experiments on BGCs could provide useful information on the 
importance of CP-AMPARs in OECs.  
While CP-AMPARs and TARPs play important roles in healthy glial cells, 
their role in glioma proliferation and growth is less clear (Jansen et al., 
2010). Gliomas have been found to express various AMPAR subunits 
(GluA1, GluA3 and GluA4), which give rise predominantly to CP-AMPARs. 
When activated these can lead to enhanced proliferation of glial tumours 
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through the Ras/Raf/MEK-1 pathway (Beretta et al., 2009). Several studies 
have shown that a downregulation of GluA1-containing CP-AMPARs 
reduces growth and proliferation of gliomas (de Groot et al., 2008). Indeed, 
the proposed AMPAR antagonist talampanel is currently in phase 2 clinical 
trials for treatment of gliomas (Iwamoto et al., 2010).  
It has also been shown that there is increased expression of the unedited 
GluA2(Q) in glial tumour cells and that activation of unedited AMPARs 
influences cells proliferation (Ishiuchi et al., 2007). There is currently no 
published work on the role of TARPs in glioma growth. It seems quite likely 
that properties of CP-AMPAR in gliomas are controlled by γ-5 and that 
knockdown of this TARP (for example with sRNAi) could potentially reduce 
the cell surface expression of CP-AMPARs to reduce the rate of 
proliferation and migration of gliomas. 
In chapter 4 we described experiments on optic nerve OPCs and found 
that, like neurons, these can undergo mGluR dependent AMPAR plasticity, 
which is regulated by the mTOR pathway and blocked by cyclohexamide 
(C-hex). Furthermore, ATP modulated the plasticity of AMPARs in OPCs 
and decreased their single-channel conductance, Surprisingly this effect 
on AMPARs was not inhibited by C-hex..  
The experiments described in Chapter 5 identify cornichon proteins in the 
surface of glial cells in the cerebellum and optic nerve. In light of recent 
work (Shi et al., 2010) it was surprising that we found CNIH3 was able to 
modify the properties of AMPARs when overexpressed in OPCs. 
Examination of the possible role of cornichons in glial cells would be 
facilitated if knockout mice were available in which CNIH2/3 knockdown 
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was under the control of a glial cell promoter. This might allow the 
identification of potential abnormalities in glial cell AMPAR properties.  
Recently abnormalities in the expression in the genes encoding the TARPs 
γ-2 have been linked with epilepsy and schizophrenia (Kato et al., 2008). 
However, it is currently unknown whether there is a correlation between 
mutations in genes encoding cornichons and specific neurological 
disorders. Interestingly, a study using gene microarray studies of animal 
models of schizophrenia has identified a reduced expression levels of 
CNIH2 in the cerebellum (Fatemi et al., 2008), raising the possibility that 
cornichons may be important in neuronal-glial communication as described 
for TARPs in this thesis.  
The importance of glia in facilitating LTP in neurons, and the role of 
proteins which regulate neuronal-glial communication, have become the 
focus of many recent studies (Haydon et al., 2009; Henneberger et al., 
2010; Zhang et al., 2009). With the advent of microarray studies we can 
now detect changes in the expression levels of many proteins linked to 
AMPAR trafficking. It is anticipated that this will provide further vital 
information on how glial cells, and their AMPARs and TARPs, are 
regulated throughout the CNS. Clearly, further studies are required to 
provide greater insight into how AMPARs are trafficked and how channel 
properties modified in glia.  
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